🏷

Classifications

Harrison's Part

Mechanistic Nosology

👪

Inheritance

1

Autosomal recessive inheritance HP:0000007

Bi-allelic (homozygous or compound heterozygous) LETM1 variants segregate with disease across 11 unrelated families; 12 of 18 affected individuals came from consanguineous unions.

Autosomal recessive inheritance

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"with 67% of the individuals (12/18) being from consanguineous unions"

The high proportion of consanguineous families is the expected pedigree structure for a recessive disease and supports the bi-allelic requirement.

◈

Mechanistic Hypotheses

2

LETM1 is the mitochondrial K+/H+ exchanger (KHE)

letm1_k_h_exchange CANONICAL

Evidence balance 1 support

The original and best-supported assignment. Yeast submitochondrial particle studies established electroneutral, obligatorily coupled K+/H+ exchange that is abolished in yol027 (Mdm38/LETM1 homolog) null mitochondria and restored by the human LETM1 protein. Drosophila DmLETM1 likewise complements KHE activity in LETM1-deficient yeast. Critically, this is the arm that the human disease study assayed directly: proband fibroblasts and muscle showed defective mitochondrial K+ efflux, and the swelling phenotype is what uncompensated electrophoretic K+ uptake predicts.

Pathograph links

Biallelic LETM1 Loss of Function -> Defective Mitochondrial K+/H+ Exchange DIRECT Loss of LETM1 removes the transport activity that couples K+ efflux to H+ entry across the inner membrane.

Show evidence (1 reference)

PMID:15904662 SUPPORT In Vitro

"Both activities are abolished when the yeast Yol027p protein is absent (yol027Delta mutant SMPs), indicating that it has an essential role in this reaction. The replacement of the yeast Yol027p by the human Letm1 protein restores K+/H+ exchange activity confirming functional homology of the..."

Loss-and-rescue in submitochondrial particles is the primary evidence that LETM1 is required for mitochondrial K+/H+ exchange.

LETM1 is the mitochondrial Ca2+/H+ antiporter (CHE)

letm1_ca_h_exchange ALTERNATIVE

Evidence balance 1 support 1 refute

A genome-wide Drosophila RNAi screen identified Letm1 as mediating coupled Ca2+/H+ exchange, supported by knockdown, overexpression and liposome reconstitution of purified protein; a Letm1 heterozygous mouse showed reduced mitochondrial Ca2+ uptake and impaired ATP generation. This assignment is contested rather than settled: the mitochondrial Ca2+/H+ exchanger was subsequently attributed to TMBIM5/MICS1, a LETM1 interactor, with the authors concluding explicitly that TMBIM5 and not LETM1 is that exchanger. A structural study of the LETM1 F-EF-hand nonetheless shows the domain acts as a two-way regulator of matrix Ca2+, so a regulatory rather than transporting role in Ca2+ handling remains plausible. Do not treat this group as established mechanism for the human disease.

Pathograph links

Biallelic LETM1 Loss of Function -> Perturbed Mitochondrial Calcium Handling UNKNOWN A contested second arm. Whether loss of LETM1 disturbs matrix Ca2+ by removing a Ca2+/H+ antiporter, by removing a regulator of one, or only indirectly through the collapse of the H+ gradient, is unresolved - see the `letm1_ca_h_exchange` hypothesis group and the transport-identity controversy in `discussions`.

Perturbed Mitochondrial Calcium Handling -> Cellular Energy Failure in High-Demand Tissues INDIRECT UNKNOWN INTERMEDIATES Matrix Ca2+ tunes the rate-limiting dehydrogenases of the TCA cycle, so disturbed Ca2+ handling would reduce ATP output independently of the structural respiratory chain defect. Demonstrated only in knockdown cells and heterozygous mice.

Show evidence (2 references)

PMID:19797662 SUPPORT In Vitro

"RNAi knockdown, overexpression, and liposome reconstitution of the purified Letm1 protein demonstrate that Letm1 is a mitochondrial Ca2+/H+ antiporter."

The primary claim that LETM1 is the Ca2+/H+ antiporter, from the screen and reconstitution study that originated this hypothesis.

PMID:36321428 REFUTE In Vitro

"Taken together, we demonstrate that TMBIM5, but not LETM1, is the long-sought mitochondrial CHE, involved in setting and regulating the mitochondrial proton gradient."

Directly contradicts the Ca2+/H+ antiporter assignment for LETM1, attributing that activity to its interactor TMBIM5 instead.

?

Discussions and Knowledge Gaps

2

Is LETM1 the mitochondrial K+/H+ exchanger, a Ca2+/H+ antiporter, both, or neither - and which activity is the one whose loss causes this disease?

CONTROVERSY OPEN letm1_transport_identity

Attached to

pathophysiology#Defective Mitochondrial K+/H+ Exchange pathophysiology#Perturbed Mitochondrial Calcium Handling mechanistic_hypotheses#letm1_k_h_exchange mechanistic_hypotheses#letm1_ca_h_exchange

This is a live disagreement in the primary literature, not a gap in curation, and the entry deliberately represents both positions rather than picking a side. The K+/H+ assignment came first, from submitochondrial particle kinetics with loss and cross-species rescue, and is the activity the human disease study actually measured in proband material. The Ca2+/H+ assignment came from a genome-wide RNAi screen with liposome reconstitution of purified protein, which is strong biochemistry, but a later study identified TMBIM5/MICS1 - a validated LETM1 interactor - as the Na+- independent Ca2+/H+ exchanger and concluded explicitly that LETM1 is not. A mechanistic objection applies to both transport claims: it is unclear how a single-transmembrane protein could mediate ion exchange at all, which is why oligomer and protein-complex models have been proposed. Alternative core functions - a mitochondrial translation factor, a ribosome or mtDNA organiser, a cristae and respiratory complex stabiliser - are also on the table, and a 2024 review concludes the core function remains elusive. Practical consequence for this entry: the pathograph spine runs through the K+/H+ arm, because that is what was assayed in patients' own cells and what the nigericin rescue supports. The Ca2+ arm is curated as a separate node with an ALTERNATIVE hypothesis group and no patient-level evidence. Anyone revising this entry should not quietly promote the Ca2+ arm without new human data.

Show evidence (3 references)

PMID:39481506 SUPPORT Other

"Undisputedly, osmoregulatory processes are essential for mitochondrial functionality, but the pleiotropic aspects of LETM1 challenges us to understand the core function of LETM1, which still remains elusive."

A 2024 review states directly that LETM1's core function is unresolved, which is the controversy this discussion records.

PMID:22641639 SUPPORT Other

"To add further complexity, LETM1 has been recently proposed to catalyze mitochondrial H+–Ca2+ exchange, which would imply a role in mitochondrial Ca2+ homeostasis as well."

Frames the Ca2+ proposal as an addition to, and complication of, the established K+/H+ role - the shape of the dispute.

PMID:30012579 SUPPORT In Vitro

"we show that LETM1 is associated with mitochondrial ribosomes, is required for mitochondrial DNA distribution and expression, and regulates the activity of an ancillary metabolic enzyme, pyruvate dehydrogenase"

Evidence for a third candidate core function - mitochondrial translation and mtDNA organisation - that is neither of the two transport hypotheses, which is why the controversy is not simply K+ versus Ca2+.

What determines whether a given bi-allelic LETM1 genotype produces a slowly progressive course compatible with survival into the fourth decade or a rapid course fatal in infancy?

KNOWLEDGE GAP OPEN letm1_genotype_phenotype_and_natural_history

Attached to

progression#Progressive course genetic#LETM1 treatments#

The entire clinical literature is one cohort of 18 individuals from 11 families, published in 2022, with no subsequent case series located in PubMed as of this curation. Within that cohort the tempo of progression varies from rapid infantile death to survival at 35 and 39 years, but the cohort is far too small to correlate that range with allele class - missense versus truncating, or residual K+/H+ exchange activity in the yeast assay. Six of the eighteen were deceased with only limited clinical records available, which further limits phenotyping. No prospective natural-history study, no biomarker of progression beyond lactate, and no therapeutic trial exists. The `treatments#` section is attached here because its emptiness of disease-modifying options is itself the gap: nigericin corrected membrane potential in proband fibroblasts, which is a mechanistic lead worth pursuing, but it failed to prevent epilepsy in the rat knockdown model and has never been tested clinically. Ketone bodies restored mitochondrial shape without restoring membrane potential, so that lead is also unresolved.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Only limited clinical data were obtainable from 6 deceased persons belonging to families 3 and 10."

Documents the incompleteness of phenotyping within the only reported cohort, which is the basis for this gap.

⚙

Pathophysiology

8

Biallelic LETM1 Loss of Function

Mechanism confidence: Established

Two variant LETM1 alleles reduce or abolish the function of the inner mitochondrial membrane osmoregulator. LETM1 is a single-transmembrane protein of the SLC55 family with a large matrix-facing C-terminal domain carrying coiled-coil and EF-hand-like motifs, and it assembles into a high-molecular-weight complex. Missense, frameshift, stop-loss and splice-region alleles are all reported; the yeast complementation assay distinguished disease alleles from rare benign LETM1 variants.

LETM1 is the mitochondrial Ca2+/H+ antiporter (CHE) LETM1 is the mitochondrial K+/H+ exchanger (KHE)

Genetic context variant_origin: GERMLINE zygosity: HOMOZYGOUS functional_impact_category: LOSS_OF_FUNCTION

LETM1 potassium/proton antiporter activity GO:0015386 ⇓ LOSS OF FUNCTION

Downstream

Defective Mitochondrial K+/H+ Exchange Loss of LETM1 removes the transport activity that couples K+ efflux to H+ entry across the inner membrane.

Perturbed Mitochondrial Calcium Handling A contested second arm. Whether loss of LETM1 disturbs matrix Ca2+ by removing a Ca2+/H+ antiporter, by removing a regulator of one, or only indirectly through the collapse of the H+ gradient, is unresolved - see the `letm1_ca_h_exchange` hypothesis group and the transport-identity controversy in `discussions`.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) (MIM: 604407) is a ubiquitously expressed and phylogenetically highly conserved nuclear gene."

Establishes LETM1 as a ubiquitously expressed conserved nuclear gene, which is why its loss produces multisystem rather than tissue-restricted disease.

Defective Mitochondrial K+/H+ Exchange

Mechanism confidence: Established

Mitochondrial K+/H+ exchange is electroneutral and obligatorily coupled: a K+ gradient drives H+ against its own concentration gradient and vice versa. This activity is what normally offsets the electrophoretic K+ influx driven by the inner membrane potential, and so sets matrix volume. In LETM1 deficiency the exchange fails and K+ efflux is lost.

mitochondrial potassium ion transmembrane transport GO:0071805 ↓ DECREASED coupled proton transport across the inner mitochondrial membrane GO:1902600 ↓ DECREASED

Experimental models

Saccharomyces cerevisiae mdm38/letm1-delta complementation assay OTHER Cross-species complementation quantifies the K+/H+ exchange competence of each human LETM1 allele.

Animal models

Drosophila DmLETM1 tissue-specific knockdown Fruit fly recapitulates Establishes that the LETM1 ortholog's osmoregulatory KHE activity is the conserved function whose loss produces the mitochondrial phenotype.

Downstream

Mitochondrial Matrix Swelling and Cristae Disorganization Without compensating K+ efflux, electrophoretic K+ uptake is unopposed and water follows osmotically into the matrix.

Mitochondrial Membrane Potential Depolarization Proband fibroblasts showed an irregular, reduced polarization pattern that was corrected by the synthetic K+/H+ exchanger nigericin, indicating the depolarization is downstream of the lost exchange activity rather than an independent lesion.

Show evidence (1 reference)

PMID:15904662 SUPPORT In Vitro

"K+ and H+ translocations have stoichiometries similar to those mediated by the exogenous K+/H+ exchanger nigericin, and they are shown to be essentially electroneutral and obligatorily coupled."

Characterises the exchange activity that is lost, establishing it as electroneutral and obligatorily coupled.

Perturbed Mitochondrial Calcium Handling

Mechanism confidence: Hypothetical

Contested arm, curated because the literature is genuinely divided rather than because the mechanism is established for this disease. Letm1 knockdown reduces mitochondrial Ca2+ uptake and H+ extrusion and impairs ATP generation, and the LETM1 F-EF-hand is a bidirectional regulator of matrix Ca2+; but the Na+-independent mitochondrial Ca2+/H+ exchanger has since been attributed to TMBIM5 rather than LETM1. The delineating human study assayed K+/H+ exchange, not Ca2+ flux, in proband material, so no patient-level evidence bears on this node - it rests entirely on model and in vitro systems.

LETM1 is the mitochondrial Ca2+/H+ antiporter (CHE)

mitochondrial calcium ion homeostasis GO:0051560 ↕ DYSREGULATED

Animal models

Letm1 heterozygous knockout mouse Mouse partially recapitulates Supports a link from Letm1 dosage to mitochondrial Ca2+ handling and brain energy failure, but only in the heterozygous state.

Downstream

Cellular Energy Failure in High-Demand Tissues Matrix Ca2+ tunes the rate-limiting dehydrogenases of the TCA cycle, so disturbed Ca2+ handling would reduce ATP output independently of the structural respiratory chain defect. Demonstrated only in knockdown cells and heterozygous mice.

Show evidence (2 references)

PMID:39317198 SUPPORT In Vitro

"Functionally, mutations that augmented or weakened Ca2+ binding increased or decreased matrix Ca2+, respectively, establishing F-EF as a two-way mitochondrial Ca2+ regulator."

Structural and mutational evidence that the LETM1 EF-hand regulates matrix Ca2+ in both directions, supporting a Ca2+-regulatory role even if LETM1 is not itself the Ca2+/H+ exchanger.

PMID:29123128 SUPPORT In Vitro

"Our findings delineate a mechanism by which PINK1 regulates mitochondrial Ca2+ level through LETM1 and suggest a model by which PINK1 loss leads to deficient phosphorylation of LETM1 and impaired mitochondrial Ca2+ transport."

Places LETM1 downstream of PINK1 in mitochondrial Ca2+ regulation in neurons, which is the most direct link between LETM1 Ca2+ handling and neuronal vulnerability - though shown in a Parkinson-disease model system, not in LETM1-variant patient cells.

Mitochondrial Matrix Swelling and Cristae Disorganization

Mechanism confidence: Established

The pathological hallmark of LETM1 depletion across every organism studied: the matrix swells and becomes less electron-dense, cristae are lost, and the network fragments into donut segments, punctate units and enlarged bodies separated from the main network. Transmission electron microscopy of fibroblasts from two probands reproduced this directly. The reciprocal experiment is informative - LETM1 overexpression condenses the matrix and swells cristae - confirming that LETM1 dosage sets matrix volume in both directions.

patient-derived dermal fibroblast CL:0000057

cristae formation GO:0042407 ↓ DECREASED mitochondrion organization GO:0007005 ⚠ ABNORMAL mitochondrial matrix volume homeostasis ⚠ ABNORMAL

Experimental models

Proband-derived dermal fibroblasts carrying bi-allelic LETM1 variants PRIMARY CELL CULTURE Transmission electron microscopy of fibroblasts from two affected individuals reproduced the swollen matrix and cristae loss directly in patient genotype.

Animal models

Rat lentiviral Letm1 knockdown Rat recapitulates Reproduces mitochondrial swelling in vivo on Letm1 depletion and links it to reduced respiratory chain subunit content.

Downstream

Respiratory Chain Complex Deficiency Loss of cristae architecture destabilises the respiratory chain complexes that the cristae membranes house. LETM1 knockdown impairs respiratory chain complex formation, and the swelling is not simply a consequence of respiratory chain loss - cells without mitochondrial DNA lose active respiratory chains yet keep tubular networks.

Show evidence (4 references)

PMID:36055214 SUPPORT In Vitro

"LETM1 variants cause swollen mitochondria and loss of cristae. The ultrastructure of control (C1) and affected individual (F5 and F10) fibroblasts was investigated by transmission electron microscopy"

Demonstrates the swelling and cristae loss in fibroblasts from affected individuals carrying the disease variants, not only in knockdown models.

PMID:17606466 SUPPORT In Vitro

"The opposite effect is achieved by overexpression of Letm1. Overexpression increases the electron density of the mitochondrial matrix and swelling of cristae."

The reciprocal dosage experiment, performed in the cultured mammalian cells that are this study's cell-based arm - raising Letm1 condenses the matrix instead of swelling it. Establishes that Letm1 sets matrix volume in both directions rather than being permissive for it.

PMID:17606466 SUPPORT Model Organism

"in C. elegans lead to swellings along the lengths of mitochondria, consistent with the phenotype observed in yeast."

The whole-organism arm of the same study - a C. elegans letm-1 mutant reproduces the swelling seen in cell culture, so the lesion is conserved rather than an artefact of cultured cells. Quoted as a partial sentence because the source states the human-cell and C. elegans results in one sentence, and this item is graded for the animal result alone.

+ 1 more reference

Mitochondrial Membrane Potential Depolarization

Mechanism confidence: Provisional

Proband fibroblasts showed an irregular polarization pattern by membrane-potential-dependent dye, with reduced potential in two families. Nigericin restored it; ketone bodies did not, although ketone bodies did restore elongated mitochondrial shapes. The dissociation is informative - it separates the osmotic/potential lesion from the morphological one.

regulation of mitochondrial membrane potential GO:0051881 ↓ DECREASED

Experimental models

Proband-derived dermal fibroblasts carrying bi-allelic LETM1 variants PRIMARY CELL CULTURE Membrane-potential-dependent dye revealed an irregular polarization pattern, and the nigericin rescue arm establishes the K+-handling origin of the depolarization.

Downstream

Respiratory Chain Complex Deficiency A reduced protonmotive force lowers the thermodynamic driving force for oxidative phosphorylation and compounds the structural complex deficiency.

Respiratory Chain Complex Deficiency

Mechanism confidence: Established

Every affected individual in the delineating cohort had a respiratory chain complex deficiency - the only feature present in 100% of the cohort. Proband fibroblasts and muscle showed reduced levels and activity of electron transfer chain proteins, consistent with the loss of cristae architecture that houses them. Conformance note: this node conforms to the module's central bioenergetic node only in part. The module pairs decreased oxidative phosphorylation with increased reactive oxygen species; decreased oxidative phosphorylation is directly evidenced in these patients, whereas no ROS measurement is reported in the LETM1 cohort and none is asserted here. The module's upstream node - age-related mitochondrial damage and somatic mtDNA mutation - does not apply to a childhood-onset primary nuclear-gene defect, which is why conformance is declared at this node alone and not along the module's whole chain.

oxidative phosphorylation GO:0006119 ↓ DECREASED mitochondrial respiratory chain complex assembly GO:0033108 ↓ DECREASED

Downstream

Cellular Energy Failure in High-Demand Tissues Reduced electron transfer chain content and activity lowers ATP supply, which is limiting first in the tissues with the highest oxidative demand.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"The common features included respiratory chain complex deficiencies (100%), global developmental delay (94%), optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%)"

Respiratory chain complex deficiency was present in every affected individual, making it the obligate biochemical consequence of the lesion.

Cellular Energy Failure in High-Demand Tissues

Mechanism confidence: Provisional

ATP supply falls below demand preferentially in the tissues with the highest and least interruptible oxidative requirement - retinal ganglion cells and their long unmyelinated axons, cochlear hair cells, cerebellar Purkinje cells, cortical neurons, cardiomyocytes, skeletal muscle and pancreatic beta cells. This tissue-selectivity, from a defect in a ubiquitously expressed gene, is the standard explanation for the organ pattern of mitochondrial disease; here it is inferred from that general principle plus the observed organ involvement rather than measured tissue by tissue, hence PROVISIONAL. Elevated serum lactate in 8 of 12 tested individuals is the systemic correlate.

retinal ganglion cell CL:0000740 cochlear inner hair cell CL:0000589 cerebellar Purkinje cell CL:0000121 cardiomyocyte CL:0000746 skeletal muscle fiber CL:0008002 pancreatic beta cell CL:0000169

ATP synthesis coupled electron transport GO:0042773 ↓ DECREASED

Animal models

Zebrafish letm1 knockout Zebrafish partially recapitulates Complete loss of Letm1 in a whole vertebrate depletes the NAD+/NADH pool and deregulates mitochondrial nucleotide metabolism, which is a redox and energy-supply lesion downstream of the same osmoregulatory defect.

Downstream

Progressive Neurodegeneration and Multisystem Involvement

Cardiomyopathy

Myopathy

Muscular Wasting Wasting follows the same energy-failure route as the myopathy, with the neurogenic component seen on nerve conduction studies as an additional intermediate.

Diabetes Mellitus

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Elevated serum lactate was confirmed in 8/12 (67%) affected individuals."

Systemic lactate elevation is the biochemical signature of a shift to anaerobic metabolism when oxidative ATP supply is insufficient.

Progressive Neurodegeneration and Multisystem Involvement

Mechanism confidence: Established

Sustained energy failure in post-mitotic, high-demand neural tissue produces a variably progressive neurodegenerative course rather than a static encephalopathy: developmental regression, loss of ambulation, cerebellar and pontine atrophy, and optic nerve and chiasmal atrophy on imaging. Onset ranges from birth to 8 years, and the rate of progression is heterogeneous across families.

neuron CL:0000540

neuron apoptotic process GO:0051402 ↑ INCREASED

Downstream

Global Developmental Delay

Optic Atrophy

Sensorineural Hearing Loss

Cerebellar Ataxia

Epilepsy

Spasticity

Developmental Regression

Loss of Ambulation The functional endpoint of the regression, reached through the combined corticospinal and cerebellar motor lesions rather than directly.

Cerebellar Atrophy

Pontine Hypoplasia The pontine lesion is reported in the same infratentorial imaging description as the cerebellar atrophy and in the same proband, so it is wired from the same node.

Spastic-Ataxic Gait The gait is the functional convergence of the separately wired corticospinal (spasticity) and cerebellar (ataxia) lesions.

Impaired Speech Acquisition Mediated by the sensorineural hearing loss, with a motor-speech contribution from the spastic dysarthria recorded in the cohort.

Cataract

Hypotonia

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"These manifested as a spectrum of predominantly infantile-onset (14/18, 78%) and variably progressive neurological, metabolic, and dysmorphic symptoms, plus multiple organ dysfunction associated with neurodegeneration."

Characterises the clinical outcome as infantile-onset, progressive and multisystem with neurodegeneration, which is this node.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

37

Cardiovascular 2

Cardiomyopathy FREQUENT HP:0001638

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Other features included bilateral cataracts (42%), cardiomyopathy (36%), and diabetes (27%)."

Reports cardiomyopathy in 36% of affected individuals.

Pericardial Effusion OCCASIONAL HP:0001698

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"cardiomyopathy (5/14, 36%) with pericardial effusion (3/11, 27%)"

Gives the cohort frequency of pericardial effusion and its relationship to the cardiomyopathy.

Digestive 1

Feeding Difficulties HP:0011968

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"The common presenting symptoms were global developmental delay, cognitive and motor regression, failure to thrive, central hypotonia, respiratory distress, and feeding difficulties."

Lists feeding difficulties among the common presenting symptoms of the cohort.

Ear 2

Sensorineural Hearing Loss FREQUENT Sensorineural hearing impairment HP:0000407

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"

Reports sensorineural hearing loss in 78% of affected individuals.

Low-Set Ears HP:0000369

Show evidence (2 references)

PMID:36055214 SUPPORT Human Clinical

"facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"

Names low-set ears as one of the constituent craniofacial abnormalities in the cohort.

PMID:36055214 SUPPORT Human Clinical

"F1:S1 and F1:S2 show long thin faces, low-set ears, and teeth abnormalities."

Documents low-set ears directly in two named affected individuals.

Endocrine 1

Diabetes Mellitus OCCASIONAL HP:0000819

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Other features included bilateral cataracts (42%), cardiomyopathy (36%), and diabetes (27%)."

Reports diabetes in 27% of affected individuals.

Eye 3

Optic Atrophy VERY_FREQUENT HP:0000648

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"In (iii) arrowheads point at the severe optic nerve and chiasm atrophy in 2 different individuals"

Neuroimaging confirmation of optic nerve and chiasmal atrophy, the structural correlate of the clinical optic atrophy.

Cataract FREQUENT HP:0000518

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Other features included bilateral cataracts (42%), cardiomyopathy (36%), and diabetes (27%)."

Reports bilateral cataracts in 42% of affected individuals.

Nystagmus FREQUENT HP:0000639

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Other frequent neurological symptoms were nystagmus (7/13, 54%)"

Reports nystagmus in 54% of the individuals in whom it was assessed.

Head and Neck 5

Facial Dysmorphism FREQUENT Abnormal facial shape HP:0001999

Show evidence (2 references)

PMID:36055214 SUPPORT Human Clinical

"facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"

Gives the cohort frequency of facial dysmorphism and enumerates its component features.

PMID:36055214 SUPPORT Human Clinical

"These included thin habitus, low set ears, microcephaly, micrognathia, and low body weight."

The discussion attributes this dysmorphic feature set to bi-allelic LETM1 variants as a spectrum not previously ascribed to the LETM1 deletion.

Microcephaly FREQUENT HP:0000252

Show evidence (2 references)

PMID:36055214 SUPPORT Human Clinical

"Craniofacial abnormalities included occipitofrontal circumference below third percentile in 2/6 persons"

Quantifies reduced occipitofrontal circumference in the fraction of the cohort in whom head circumference was measured.

PMID:36055214 SUPPORT Human Clinical

"It has been previously speculated that the most probable cause of growth deficiency, microcephaly, and the characteristic facial features in WHS is due to haploinsufficiency of WHSC1, a region located far from LETM1."

Records that the microcephaly of Wolf-Hirschhorn syndrome is attributed to a different gene, so the microcephaly seen here is not simply the WHS finding recurring.

Micrognathia HP:0000347

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"

Names micrognathia as one of the constituent craniofacial abnormalities in the cohort.

High Palate HP:0000218

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"

Names a high arched palate as one of the constituent craniofacial abnormalities in the cohort.

Teeth Abnormalities Abnormality of the dentition HP:0000164

Show evidence (2 references)

PMID:36055214 SUPPORT Human Clinical

"facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"

Names teeth abnormalities as one of the constituent craniofacial abnormalities in the cohort.

PMID:36055214 SUPPORT Human Clinical

"F1:S1 and F1:S2 show long thin faces, low-set ears, and teeth abnormalities."

Documents teeth abnormalities directly in two named affected individuals.

Musculoskeletal 6

Muscular Wasting FREQUENT Skeletal muscle atrophy HP:0003202

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"spasticity (8/15, 53%), hypotonia (11/18, 61%), muscular wasting (7/10, 70%), and cerebellar ataxia (7/9, 78%)"

Reports muscular wasting in 70% of the individuals in whom it was assessed, the highest-frequency neuromuscular feature in the cohort.

Spasticity FREQUENT HP:0001257

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"epilepsy (67%), spasticity (53%), and myopathy (50%)"

Reports spasticity in 53% of affected individuals.

Myopathy FREQUENT HP:0003198

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Hence, electromyography and nerve conductions studies available from 5 individuals showed neurogenic (3/5) and myopathic changes (2/4)."

Documents the electrophysiological basis of the myopathy, and shows the neuromuscular picture includes a neurogenic component.

Hypotonia FREQUENT HP:0001252

Show evidence (2 references)

PMID:36055214 SUPPORT Human Clinical

"spasticity (8/15, 53%), hypotonia (11/18, 61%), muscular wasting (7/10, 70%), and cerebellar ataxia (7/9, 78%)"

Reports central hypotonia in 61% of the cohort, the denominator for this frequency.

PMID:36055214 SUPPORT Human Clinical

"These manifested as a spectrum of predominantly infantile-onset (14/18, 78%) and variably progressive neurological, metabolic, and dysmorphic symptoms"

Establishes the infantile-onset neurological spectrum in which hypotonia is tabulated as a presenting feature.

Cytochrome C Oxidase-Negative Muscle Fibers HP:0003688

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Muscle biopsy was available from 7 persons and of these, 5 had abnormal findings including scattered necrotic and regenerating COX-deficient fibers with an excess of internal nuclei"

Documents COX-deficient fibers on muscle biopsy and the fraction of biopsied individuals with abnormal histology.

Ragged-Red Muscle Fibers HP:0003200

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"COX-deficient multiple ragged-red fibers with increased fiber unisometry (F8:S1)"

Reports ragged-red fibers in the one individual in whom they were seen.

Nervous System 14

Global Developmental Delay VERY_FREQUENT HP:0001263

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"The common features included respiratory chain complex deficiencies (100%), global developmental delay (94%), optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%)"

Reports global developmental delay in 94% of affected individuals.

Cerebellar Ataxia FREQUENT HP:0001251

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"

Reports cerebellar ataxia in 78% of affected individuals.

Epilepsy FREQUENT Seizure HP:0001250

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"

Reports epilepsy in 67% of affected individuals.

Impaired Speech Acquisition FREQUENT Delayed speech and language development HP:0000750

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"impaired speech acquisition (6/9, 67%) were among the common neurodevelopmental symptoms"

Reports impaired speech acquisition in 67% of the individuals in whom it was assessed, as a common neurodevelopmental symptom of the cohort.

Developmental Regression FREQUENT HP:0002376

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Developmental regression was later present in 9/13 (69%) affected individuals"

States the phenotype and its cohort fraction directly, which is both the basis for the FREQUENT band and a direct rather than inferred support for the phenotype itself.

Loss of Ambulation HP:0002505

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"with loss of independent ambulation by a mean age of 5.4 ± 3.2 years (range 2–12)"

Reports loss of independent ambulation and the age at which it occurred across the cohort.

Cerebellar Atrophy HP:0001272

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"severe cerebellar atrophy (arrows) and pontine hypoplasia (arrowheads) are shown, while in (ii) (F6:S1), only mild vermian hypoplasia is noted"

Reports the cerebellar imaging findings and their range of severity across the cohort.

Hyperkinetic Movement Disorders FREQUENT Hyperkinetic movements HP:0002487

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"myopathy (6/12, 50%), hyperkinetic movement disorders (4/12, 33%)"

Reports hyperkinetic movement disorders in 33% of the individuals in whom they were assessed.

Spastic-Ataxic Gait FREQUENT Spastic ataxia HP:0002497

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"hyperkinetic movement disorders (4/12, 33%), and spastic-ataxic gait (3/9, 33%)"

Reports spastic-ataxic gait in 33% of the individuals in whom gait was assessed.

Hyperreflexia FREQUENT HP:0001347

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"combined with brisk deep tendon reflexes (4/10, 40%)"

Reports brisk deep tendon reflexes in 40% of the individuals in whom reflexes were assessed.

Extensor Plantar Response FREQUENT Babinski sign HP:0003487

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"brisk deep tendon reflexes (4/10, 40%), upgoing plantar response (4/9, 44%)"

Reports upgoing plantar responses in 44% of the individuals in whom plantar responses were assessed.

Peripheral Neuropathy FREQUENT HP:0009830

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"upgoing plantar response (4/9, 44%), and peripheral neuropathy (3/9, 33%)."

Reports peripheral neuropathy in 33% of the individuals in whom it was assessed.

Pontine Hypoplasia Hypoplasia of the pons HP:0012110

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Three individuals showed infratentorial abnormalities, with severe pontine hypoplasia and cerebellar atrophy in a proband from family 1 and mild vermian hypoplasia in 2 probands from family 3 and family 6."

Reports severe pontine hypoplasia as a distinct infratentorial finding in the imaged subset of the cohort.

Ventriculomegaly HP:0002119

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Other minor and non-specific findings were mild supratentorial atrophy and mild ventricular dilatation noted in 2 persons each."

Reports mild ventricular dilatation and records the source's own characterisation of it as minor and non-specific.

Respiratory 1

Respiratory Distress HP:0002098

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"The common presenting symptoms were global developmental delay, cognitive and motor regression, failure to thrive, central hypotonia, respiratory distress, and feeding difficulties."

Lists respiratory distress among the common presenting symptoms of the cohort.

Cellular 1

Mitochondrial Respiratory Chain Defect OBLIGATE Mitochondrial respiratory chain defects HP:0200125

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"The common features included respiratory chain complex deficiencies (100%)"

Respiratory chain complex deficiency was present in 100% of the cohort, supporting an obligate frequency.

Growth 1

Failure to Thrive HP:0001508

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"The common presenting symptoms were global developmental delay, cognitive and motor regression, failure to thrive, central hypotonia, respiratory distress, and feeding difficulties."

Lists failure to thrive among the common presenting symptoms of the cohort.

🧬

Genetic Associations

1

LETM1 (Bi-allelic ultra-rare missense and loss-of-function LETM1 variants are the cause of this disease. LETM1 (also SLC55A1) encodes an inner mitochondrial membrane protein of the SLC55 solute carrier family with an osmoregulatory function controlling mitochondrial volume and cation homeostasis. Reported alleles include missense (c.878T>A p.Ile293Asn; c.1072G>A p.Asp358Asn), frameshift (c.2094del p.Asp699Metfs*13), stop-loss (c.2220G>C p.*740Tyrext26) and splice-region (c.2071-9C>G) changes.)

Gene: LETM1 hgnc:6556 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"we have identified 18 affected individuals from 11 unrelated families harboring ultra-rare bi-allelic missense and loss-of-function LETM1 variants and clinical presentations highly suggestive of mitochondrial disease"

Establishes the gene-disease relationship: bi-allelic LETM1 variants in 11 independent families with a mitochondrial-disease presentation.

Variants (1)

LETM1 c.878T>A (p.Ile293Asn) Pathogenic

Missense variant in the family 1 proband, reported alongside the frameshift c.2094del in trans.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"F1:S2, c.878T>A (p.Ile293Asn) and c.2094del (p.Asp699Metfs∗13)"

Records the compound-heterozygous allele pair in family 1.

💊

Medical Actions

3

Supportive and Multidisciplinary Care

Action: Supportive Care NCIT:C15747

No disease-modifying therapy exists. Management is entirely supportive and follows general mitochondrial-disease practice: multidisciplinary surveillance for the organ systems known to be involved (vision, hearing, cardiac, endocrine), nutritional support, and management of the progressive neurological disability. This entry records the absence of targeted therapy honestly rather than listing speculative agents.

Mechanism Target:

Progressive Neurodegeneration and Multisystem Involvement — Symptomatic only - supportive care addresses the consequences of neurodegeneration and does not modify the upstream mitochondrial lesion.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"plus multiple organ dysfunction associated with neurodegeneration"

The multiorgan involvement documented in the cohort is what makes multidisciplinary surveillance the appropriate management approach.

Antiseizure Medication

Action: Pharmacotherapy NCIT:C15986

Agent: anticonvulsant agent NCIT:C264

Platform: Small molecule

Symptomatic control of the epilepsy affecting 67% of the cohort. No LETM1-specific anticonvulsant strategy has been reported, and the source cohort does not report seizure-treatment outcomes, so no agent is recommended here over any other.

Mechanism Target:

Epilepsy — Symptomatic suppression of seizures without altering the mitochondrial lesion.

Target Phenotypes: Seizure HP:0001250

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"

Establishes epilepsy as a frequent feature of the cohort and therefore a target for symptomatic pharmacotherapy.

Genetic Counseling

Action: Genetic Counseling NCIT:C15240

Autosomal recessive inheritance with a 25% recurrence risk for siblings. Particularly relevant given that two-thirds of reported affected individuals came from consanguineous unions, where carrier testing of the extended family is informative.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"with 67% of the individuals (12/18) being from consanguineous unions"

The consanguinity rate in reported families is what makes recessive recurrence-risk counseling and cascade carrier testing valuable.

🔬

Biochemical Markers

3

Serum lactate (PRESENT)

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Elevated serum lactate was confirmed in 8/12 (67%) affected individuals."

Gives the frequency of lactate elevation in the tested cohort.

Urine 3-methylglutaconic acid (PRESENT)

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Urine organic acids were analyzed in 11 affected individuals and were abnormal in 9 of them with 3-methylglutaconic acid excretion (5/11)"

Gives the frequency of abnormal urine organic acids and specifically of 3-methylglutaconic aciduria in the tested cohort.

Plasma alanine (PRESENT)

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Plasma amino acids were abnormal in 4/9 tested with mildly elevated alanine (501–597 μmol/L, normal range 232–494)"

Reports the frequency and magnitude of the alanine elevation with its reference interval.

📈

Progression

3

Presentation

Age: Birth to 8 years; 78% (14/18) in infancy

Age at onset ranges from birth to 8 years, with 78% (14/18) presenting in infancy. Presenting features are typically hypotonia, developmental delay and visual inattention.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"These manifested as a spectrum of predominantly infantile-onset (14/18, 78%)"

Establishes infantile onset as the predominant presentation.

Progressive course

Age: Infancy to fourth decade

The course is heterogeneous and is explicitly classified in the source as slow, moderate or rapid across different families, in quantified proportions - rapid in 9 of 18 (50%), moderately fast in 4 of 18 (22%) and slow in 5 of 18 (28%). Slowly progressive individuals survived into the third and fourth decades (35, 25, 24 and 39 years at last report), whereas rapidly progressive individuals died in infancy or early childhood, several before one year of age. Loss of ambulation occurred at 12 years, 6 years and 2.5 years in three individuals. This spread in tempo, rather than a difference in mechanism, is the main axis of clinical variability and is why no subtypes are curated.

Show evidence (2 references)

PMID:36055214 SUPPORT Human Clinical

"and variably progressive neurological, metabolic, and dysmorphic symptoms, plus multiple organ dysfunction associated with neurodegeneration"

The source characterises the course as variably progressive, which is what this phase records.

PMID:36055214 SUPPORT Human Clinical

"The disease progressed rapidly in 9/18 (50%), moderately fast in 4/18 (22%), and slowly in 5/18 (28%) affected individuals."

Quantifies the three progression tempos across the cohort, which is what makes the heterogeneity a measured distribution rather than an impression.

Mortality

Age: 2 months to 8 years in those who died

Half the reported cohort (9 of 18) died of rapidly progressing disease between 2 months and 8 years of age; the 9 survivors had a median age of 15 years (range 1-39) at last follow-up. Mortality therefore tracks the progression tempo directly - the rapid-course group and the deceased group are effectively the same 50% of the cohort - so this is the outcome half of the tempo heterogeneity recorded in the phase above, not an independent axis. Numbers are from a single 18-person ascertained cohort and should not be read as a population survival estimate.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"Half of the persons (9/18) succumbed to their rapidly progressing disease at an early age"

Establishes that half the reported cohort died early of progressive disease.

📊

Prevalence

1

Worldwide

Cases In Literature Ultra Rare

18 affected individuals from 11 unrelated families in the 2022 delineating cohort, ascertained by exome sequencing and international gene matching. Families were of Pakistani, Caucasus, Middle Eastern, European and Mexican origin. No population-based prevalence or incidence estimate exists, and none is asserted here - a rate would be manufactured. Because ascertainment was through mitochondrial-disease exome cohorts, the true frequency is unknown and probably underestimated.

Show evidence (1 reference)

PMID:36055214 SUPPORT Human Clinical

"we have identified 18 affected individuals from 11 unrelated families harboring ultra-rare bi-allelic missense and loss-of-function LETM1 variants"

Gives the total number of reported cases and families, which is the only occurrence measure available for this disease.

🧫

Experimental Models

2

Proband-derived dermal fibroblasts carrying bi-allelic LETM1 variants PRIMARY_CELL_CULTURE

Primary fibroblasts from affected individuals in families 1, 2, 5 and 10, used to assay mitochondrial morphology by confocal and transmission electron microscopy, membrane potential, K+/H+ exchange activity and respiratory chain protein content. This is the highest-fidelity system available for the human disease because it carries the patients' own genotypes.

Organism

human NCBITaxon:9606

Publication

PMID:36055214

Pathograph links

Mitochondrial Matrix Swelling and Cristae Disorganization recapitulates fidelity: high Transmission electron microscopy of fibroblasts from two affected individuals reproduced the swollen matrix and cristae loss directly in patient genotype.

Limitations: Fibroblasts are not an affected tissue in this disease; the neurons, retinal ganglion cells and hair cells that degenerate clinically are not represented, and fibroblast bioenergetic demand is far lower than theirs.

Readouts

Mitochondrial ultrastructure by transmission electron microscopy

Direction: ALTERED

Interpretation: Swollen matrix and loss of cristae in proband fibroblasts relative to control.

Show evidence (1 reference)

PMID:36055214 SUPPORT In Vitro

"LETM1 variants cause swollen mitochondria and loss of cristae. The ultrastructure of control (C1) and affected individual (F5 and F10) fibroblasts was investigated by transmission electron microscopy"

Reports the ultrastructural measurement behind this readout.

Mitochondrial Membrane Potential Depolarization measures fidelity: moderate Membrane-potential-dependent dye revealed an irregular polarization pattern, and the nigericin rescue arm establishes the K+-handling origin of the depolarization.

Limitations: Reduced potential was clear in two families only, and dye-based measurement is semi-quantitative.

Readouts

Mitochondrial membrane potential after nigericin

Direction: RESTORED

Interpretation: The synthetic K+/H+ exchanger nigericin restored membrane potential to control levels, whereas ketone bodies did not.

Show evidence (1 reference)

PMID:36055214 SUPPORT In Vitro

"Treatment with the synthetic KHE nigericin to counteract the loss of K+ homeostasis reverted the decreased membrane potential to control levels in F10 and F5"

Reports the rescue measurement behind this readout.

Saccharomyces cerevisiae mdm38/letm1-delta complementation assay OTHER

The yeast W303 mdm38/letm1-delta strain, which lacks the YOL027c open reading frame encoding the yeast LETM1 homolog, transformed with human LETM1 carrying each candidate disease variant. Because the human protein restores K+/H+ exchange in this strain, the assay reads out variant function directly and was used to separate pathogenic alleles from rare benign LETM1 variants that are homozygous in gnomAD.

Organism

baker's yeast NCBITaxon:4932

Publication

PMID:36055214

Pathograph links

Defective Mitochondrial K+/H+ Exchange measures fidelity: moderate Cross-species complementation quantifies the K+/H+ exchange competence of each human LETM1 allele.

Limitations: Yeast mitochondria lack complex I and much of the cellular context of a human neuron, so the assay reports transport competence of the allele and not the disease phenotype. Functional homology between Yol027p and human LETM1 is the assumption the whole assay rests on.

Show evidence (1 reference)

PMID:15904662 SUPPORT In Vitro

"The replacement of the yeast Yol027p by the human Letm1 protein restores K+/H+ exchange activity confirming functional homology of the yeast and human proteins."

Validates the complementation assay by showing the human protein functionally replaces the yeast one.

🐁

Animal Models

4

Letm1 heterozygous knockout mouse

Homozygous Letm1 deletion is embryonic lethal before day 6.5, and about half of heterozygotes died before day 13.5. Surviving heterozygotes showed altered glucose metabolism, impaired control of brain ATP levels and increased seizure activity.

Species

Mouse

Genotype

Letm1 +/- (heterozygous null)

Publication

PMID:23716663

Pathograph links

Perturbed Mitochondrial Calcium Handling partially recapitulates fidelity: low Supports a link from Letm1 dosage to mitochondrial Ca2+ handling and brain energy failure, but only in the heterozygous state.

Limitations: This is a heterozygous model of a recessive human disease - the genotype that matches human patients is embryonic lethal in mouse, so the model cannot reproduce the human bi-allelic condition at all. It was also designed and interpreted as a Wolf-Hirschhorn haploinsufficiency model, not a model of bi-allelic LETM1 disease, and it assumes the contested Ca2+/H+ antiporter assignment.

Show evidence (1 reference)

PMID:23716663 SUPPORT Model Organism

"The surviving heterozygous mice exhibited altered glucose metabolism, impaired control of brain ATP levels, and increased seizure activity."

Supports treating Letm1 dosage as informative for brain energy failure and seizure susceptibility, with the heterozygous caveat above.

Drosophila DmLETM1 tissue-specific knockdown

Conditional RNAi depletion of the Drosophila LETM1 ortholog produced mitochondrial swelling, developmental lethality and, with neuron-specific knockdown, impaired locomotor behaviour and reduced synaptic neurotransmitter release. DmLETM1 complements K+/H+ exchange activity in LETM1-deficient yeast, tying the fly phenotype to the KHE function.

Species

Fruit fly

Genotype

DmLETM1 (CG4589) RNAi knockdown

Publication

PMID:20026556

Pathograph links

Defective Mitochondrial K+/H+ Exchange recapitulates fidelity: moderate Establishes that the LETM1 ortholog's osmoregulatory KHE activity is the conserved function whose loss produces the mitochondrial phenotype.

Limitations: An invertebrate RNAi knockdown rather than a point-mutation model of the human alleles; knockdown efficiency is graded and not equivalent to the bi-allelic human genotype.

Show evidence (1 reference)

PMID:20026556 SUPPORT Model Organism

"Taken together our results demonstrate the function of DmLETM1 as a mitochondrial osmoregulator through its KHE activity"

Supports the model as informative for the K+/H+ exchange mechanism in a whole organism.

Zebrafish letm1 knockout

A viable germline letm1-null vertebrate - notable in itself, because homozygous Letm1 deletion is embryonic lethal in mouse, so this is the only whole-vertebrate model in which complete loss of the protein can be studied at all. Mutants show deregulated mitochondrial nucleotide metabolism with reduced NAD+ and NADH pools, scarce and damaged skeletal muscle mitochondria with blurred cristae, and increased amplitude of circadian clock gene expression. The study was designed as chronobiology of Wolf-Hirschhorn seizure biology, not as a model of bi-allelic LETM1 disease.

Species

Zebrafish

Genotype

letm1-/- (16-bp TALEN deletion, protein-null)

Publication

DOI:10.26508/lsa.202101194

Pathograph links

Cellular Energy Failure in High-Demand Tissues partially recapitulates fidelity: low Complete loss of Letm1 in a whole vertebrate depletes the NAD+/NADH pool and deregulates mitochondrial nucleotide metabolism, which is a redox and energy-supply lesion downstream of the same osmoregulatory defect.

Limitations: Fidelity is graded LOW for three reasons. The readout is a redox and circadian phenotype rather than the respiratory chain deficiency that defines the human disease, and no NAD measurement exists in any affected individual, so the link to the human node is inferential. The mutants segregate into compensating and non-compensating developers, so the phenotype is not uniform even within the model. And the null genotype is viable in fish but embryonic lethal in mouse, so the species differ in how much loss of Letm1 an organism tolerates - which cautions against reading the fish severity across to human bi-allelic genotypes, most of which retain partial function.

Show evidence (2 references)

DOI:10.26508/lsa.202101194 SUPPORT Model Organism

"We show that mitochondrial nucleotide metabolism is deregulated in letm1−/− mutant fish, the rate-limiting enzyme of NAD+ production is up-regulated, while NAD+ and NADH pools are reduced."

Reports the metabolic consequence of complete Letm1 loss in a whole vertebrate, which is what makes this model informative for the energy failure node despite the caveats above.

+ 1 more reference

Rat lentiviral Letm1 knockdown

Lentiviral Letm1 knockdown in rat produced mitochondrial swelling, reduced the Letm1 target protein MT-CYB, and lowered the seizure threshold - earlier first seizure, increased frequency and duration. Notably, the synthetic K+/H+ exchanger nigericin failed to prevent epilepsy in this model.

Species

Rat

Genotype

LV-Letm1-sh lentiviral knockdown

Publication

PMID:23645710

Pathograph links

Mitochondrial Matrix Swelling and Cristae Disorganization recapitulates fidelity: moderate Reproduces mitochondrial swelling in vivo on Letm1 depletion and links it to reduced respiratory chain subunit content.

Limitations: A somatic knockdown in a pilocarpine epilepsy paradigm designed around Wolf-Hirschhorn seizure biology, not a germline bi-allelic model. The negative nigericin result here contrasts with the positive nigericin rescue of membrane potential in patient fibroblasts, so the two should not be read as the same experiment.

Show evidence (1 reference)

PMID:23645710 SUPPORT Model Organism

"Letm1 knock-down by a lentivirus bearing LV-Letm1-sh resulted in mitochondrial swelling and decreased expression of Letm1 target protein mitochondrially encoded cytochrome B (MT-CYB)."

Supports the model as informative for the swelling node and connects it to loss of a respiratory chain subunit.

{ }

Source YAML

click to show

name: LETM1-Related Childhood-Onset Neurodegeneration
creation_date: "2026-09-01T00:00:00Z"
category: Genetic
description: >-
  An ultra-rare autosomal recessive mitochondrial disease caused by bi-allelic
  loss-of-function or missense variants in LETM1, which encodes the inner
  mitochondrial membrane osmoregulator that couples K+ and H+ movement across
  that membrane. Loss of LETM1 K+/H+ exchange activity leaves electrophoretic
  K+ uptake uncompensated, so the matrix swells, cristae are lost and
  mitochondria fragment; respiratory chain complexes are destabilised and
  oxidative phosphorylation fails. The clinical result is a predominantly
  infantile-onset, variably progressive neurodegenerative disease with
  multisystem involvement - global developmental delay, optic atrophy,
  sensorineural hearing loss, cerebellar ataxia, epilepsy, spasticity and
  myopathy, with cataract, cardiomyopathy and diabetes in a minority. The
  defining cohort is 18 affected individuals from 11 unrelated families.
disease_term:
  preferred_term: LETM1-Related Childhood-Onset Neurodegeneration
  term:
    id: MONDO:0859304
    label: neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction
notes: >-
  Not Wolf-Hirschhorn syndrome. LETM1 lies in the 4p16.3 Wolf-Hirschhorn
  critical region (WHSCR-2), and dismech curates that contiguous-gene deletion
  disorder separately as `Wolf-Hirschhorn_Syndrome`. The two entries are
  distinct diseases and must not share phenotype, prevalence or evidence
  content. Wolf-Hirschhorn syndrome results from a de novo monoallelic 4p16.3
  deletion removing LETM1 together with WHSC1/NSD2, CPLX1, PIGG and other genes,
  and human deletion mapping has shown that LETM1 haploinsufficiency alone is
  neither necessary nor sufficient for the WHS seizure phenotype. This entry, by
  contrast, is the bi-allelic (recessive) LETM1 disease first delineated in 2022:
  a primary mitochondrial disorder in individuals with two variant LETM1 alleles
  and no 4p16.3 deletion, 67% of them from consanguineous unions. The historical
  interest in LETM1 as a WHS seizure candidate gene is why much of the older
  functional literature is framed around WHS; that work is cited here for LETM1
  protein function, not for WHS clinical content.

  The WHS-like dysmorphology is curated here, and it strengthens rather than
  weakens that separation. The defining cohort reports that these bi-allelic
  individuals show "a milder spectrum of WHS signs that has not been previously
  ascribed to the LETM1 deletion" - thin habitus, low-set ears, microcephaly,
  micrognathia and low body weight - and this entry records those features
  (`Facial Dysmorphism`, `Microcephaly`, `Micrognathia`, `Low-Set Ears`) rather
  than suppressing them to make the split look cleaner. Three things keep the
  two entries apart nonetheless. (1) The source itself attributes the growth
  deficiency, microcephaly and characteristic facies of WHS to haploinsufficiency
  of WHSC1, "a region located far from LETM1", and offers a putative
  LETM1-WHSC1 interaction or an undiscovered mechanism as the explanation for
  the milder overlap seen here - so it treats the shared features as convergent,
  not as one disease reached twice. (2) The overlap is partial and attenuated:
  facial dysmorphism in 4/10 and an occipitofrontal circumference below the
  third percentile in 2/6, a mild inconstant pattern against the specific and
  near-constant Greek-warrior-helmet facies of WHS. (3) The features that
  actually dominate this entry's pathograph - lactic acidosis, diabetes,
  cataract, neuropathy, proximal myopathy, cerebellar ataxia, spastic-ataxic
  gait, hyperkinetic movement disorders and pontine/cerebellar atrophy - are
  named by the same source as "not typical of WHS" and as typical instead of
  archetypal mitochondrial disorders. The dysmorphology is a minor shared
  overlay; the mitochondrial phenotype is the disease.

  Lump/split: the MONDO parent is the broad `MONDO:0024237` inherited
  neurodegenerative disorder, so there is no numbered-series parent to lump
  into. No `has_subtypes` are curated. The 11 reported families share one
  reasonably conserved pathograph - every affected individual had a respiratory
  chain complex deficiency and the same osmoregulatory lesion was demonstrated
  across proband fibroblasts, muscle and yeast complementation - but rate of
  progression is heterogeneous (slow, moderate and rapid courses are all
  reported, with onset from birth to 8 years), and that heterogeneity is
  recorded in `progression` rather than split into subtypes.

  Deliberate omissions, recorded so they are not read as oversights. (1) No
  `diagnosis:` section. Diagnosis here is trio/exome or genome sequencing
  returning bi-allelic LETM1 variants in a child with a respiratory chain
  deficiency; there is no LETM1-specific diagnostic assay, criteria set or
  testing algorithm published, and the defining cohort was assembled by
  genotype-first matchmaking rather than through a clinical case definition. A
  `diagnosis:` block would restate the generic mitochondrial-disease workup
  already carried by `biochemical` (lactate, urine organic acids, plasma amino
  acids) and by the `diagnostic: true` phenotypes (respiratory chain defect,
  COX-negative fibres, cerebellar atrophy). This is a gap to fill when a
  diagnostic pathway is actually published, not an omission for lack of
  material. (2) The cerebellar-ataxia phenotype stays bound to `HP:0001251`
  Ataxia, which carries "Cerebellar ataxia" as an exact synonym, with
  `clinical_course: PROGRESSIVE` alongside. `HP:0002073` Progressive cerebellar
  ataxia was considered and not used: it pre-composes the progressiveness into
  the term, whereas the cited 78% sentence establishes the ataxia and not its
  tempo, and the separable qualifier keeps those two claims distinct. (3)
  Frequency is omitted on failure to thrive, feeding difficulties, respiratory
  distress, loss of ambulation, ragged-red fibres,
  micrognathia, low-set ears, high palate, teeth abnormalities, pontine
  hypoplasia and ventriculomegaly, in each case
  because the source gives no usable denominator - the reason is recorded on
  each phenotype rather than inferred from the absence. The rule applied
  throughout is that a `frequency` band is set only where the source states the
  fraction itself: facial dysmorphism (4/10), microcephaly (2/6), pericardial
  effusion (3/11) and developmental regression (9/13) carry one; the individual components of the dysmorphic pattern
  and the two additional neuroimaging findings, which the source reports as
  narrative counts inside the six-person MRI subset, do not. (4) No
  differential-diagnosis content. The deep-research report for this entry covers
  the mitochondrial and inner-membrane differentials - OPA1, ATAD3A, TARS2,
  SERAC1, DNAJC19, HTRA2 and Barth syndrome/TAZ - and that material is real and
  usable, but it is deliberately deferred rather than dropped: writing it well
  means curating each of those entities' discriminating features against a
  single 18-person cohort, which is a follow-up of its own rather than part of
  a first entry. Recorded here so a later review does not re-raise it as an
  oversight.

  (5) No C. elegans entry in `animal_models`, although PMID:17606466's worm
  result is cited on the swelling node as `MODEL_ORGANISM` evidence. The
  abstract-only cache reports the mutant's phenotype in a single clause with no
  genotype, allele or readout detail, which is not enough to fill an
  `AnimalModel` record honestly. The zebrafish letm1 knockout, by contrast, is
  curated: it is the only viable germline vertebrate null available and its
  source is cited by DOI rather than PMID because the Life Science Alliance
  article was cached from its open-access full text.

classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    notes: >-
      Primary clinical home. Neurodegeneration dominates the presentation and
      the course - developmental delay and regression, cerebellar ataxia,
      epilepsy, spasticity, optic atrophy and sensorineural hearing loss - and
      the non-neurological features (cardiomyopathy, diabetes, cataract) are the
      minority.
    evidence:
    - reference: PMID:36055214
      reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "These manifested as a spectrum of predominantly infantile-onset (14/18, 78%) and variably progressive neurological, metabolic, and dysmorphic symptoms, plus multiple organ dysfunction associated with neurodegeneration."
      explanation: >-
        The cohort's manifestations are led by progressive neurological
        symptoms, which places the entry's primary clinical home in neurology.
  mechanistic_category:
  - classification_value: mitochondrial disease
    notes: >-
      A primary mitochondrial disease of nuclear-gene origin. Every affected
      individual had a respiratory chain complex deficiency, and the causal
      lesion is in an inner mitochondrial membrane transport protein.
    evidence:
    - reference: PMID:36055214
      reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The common features included respiratory chain complex deficiencies (100%)"
      explanation: >-
        Universal respiratory chain deficiency in the cohort is the defining
        biochemical criterion for classifying this as a mitochondrial disease.

inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Bi-allelic (homozygous or compound heterozygous) LETM1 variants segregate
    with disease across 11 unrelated families; 12 of 18 affected individuals
    came from consanguineous unions.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with 67% of the individuals (12/18) being from consanguineous unions"
    explanation: >-
      The high proportion of consanguineous families is the expected pedigree
      structure for a recessive disease and supports the bi-allelic requirement.

genetic:
- name: LETM1
  gene_term:
    preferred_term: LETM1
    term:
      id: hgnc:6556
      label: LETM1
  presence: PRESENT
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  association: >-
    Bi-allelic ultra-rare missense and loss-of-function LETM1 variants are the
    cause of this disease. LETM1 (also SLC55A1) encodes an inner mitochondrial
    membrane protein of the SLC55 solute carrier family with an osmoregulatory
    function controlling mitochondrial volume and cation homeostasis. Reported
    alleles include missense (c.878T>A p.Ile293Asn; c.1072G>A p.Asp358Asn),
    frameshift (c.2094del p.Asp699Metfs*13), stop-loss (c.2220G>C p.*740Tyrext26)
    and splice-region (c.2071-9C>G) changes.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we have identified 18 affected individuals from 11 unrelated families harboring ultra-rare bi-allelic missense and loss-of-function LETM1 variants and clinical presentations highly suggestive of mitochondrial disease"
    explanation: >-
      Establishes the gene-disease relationship: bi-allelic LETM1 variants in 11
      independent families with a mitochondrial-disease presentation.
  variants:
  - name: LETM1 c.878T>A (p.Ile293Asn)
    description: >-
      Missense variant in the family 1 proband, reported alongside the
      frameshift c.2094del in trans.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:36055214
      reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "F1:S2, c.878T>A (p.Ile293Asn) and c.2094del (p.Asp699Metfs∗13)"
      explanation: Records the compound-heterozygous allele pair in family 1.

prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    18 affected individuals from 11 unrelated families in the 2022 delineating
    cohort, ascertained by exome sequencing and international gene matching.
    Families were of Pakistani, Caucasus, Middle Eastern, European and Mexican
    origin. No population-based prevalence or incidence estimate exists, and
    none is asserted here - a rate would be manufactured. Because ascertainment
    was through mitochondrial-disease exome cohorts, the true frequency is
    unknown and probably underestimated.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we have identified 18 affected individuals from 11 unrelated families harboring ultra-rare bi-allelic missense and loss-of-function LETM1 variants"
    explanation: >-
      Gives the total number of reported cases and families, which is the only
      occurrence measure available for this disease.

mechanistic_hypotheses:
- hypothesis_group_id: letm1_k_h_exchange
  hypothesis_label: LETM1 is the mitochondrial K+/H+ exchanger (KHE)
  status: CANONICAL
  description: >-
    The original and best-supported assignment. Yeast submitochondrial particle
    studies established electroneutral, obligatorily coupled K+/H+ exchange that
    is abolished in yol027 (Mdm38/LETM1 homolog) null mitochondria and restored
    by the human LETM1 protein. Drosophila DmLETM1 likewise complements KHE
    activity in LETM1-deficient yeast. Critically, this is the arm that the
    human disease study assayed directly: proband fibroblasts and muscle showed
    defective mitochondrial K+ efflux, and the swelling phenotype is what
    uncompensated electrophoretic K+ uptake predicts.
  evidence:
  - reference: PMID:15904662
    reference_title: "Electroneutral K+/H+ exchange in mitochondrial membrane vesicles involves Yol027/Letm1 proteins."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Both activities are abolished when the yeast Yol027p protein is absent (yol027Delta mutant SMPs), indicating that it has an essential role in this reaction. The replacement of the yeast Yol027p by the human Letm1 protein restores K+/H+ exchange activity confirming functional homology of the yeast and human proteins."
    explanation: >-
      Loss-and-rescue in submitochondrial particles is the primary evidence that
      LETM1 is required for mitochondrial K+/H+ exchange.

- hypothesis_group_id: letm1_ca_h_exchange
  hypothesis_label: LETM1 is the mitochondrial Ca2+/H+ antiporter (CHE)
  status: ALTERNATIVE
  description: >-
    A genome-wide Drosophila RNAi screen identified Letm1 as mediating coupled
    Ca2+/H+ exchange, supported by knockdown, overexpression and liposome
    reconstitution of purified protein; a Letm1 heterozygous mouse showed
    reduced mitochondrial Ca2+ uptake and impaired ATP generation. This
    assignment is contested rather than settled: the mitochondrial Ca2+/H+
    exchanger was subsequently attributed to TMBIM5/MICS1, a LETM1 interactor,
    with the authors concluding explicitly that TMBIM5 and not LETM1 is that
    exchanger. A structural study of the LETM1 F-EF-hand nonetheless shows the
    domain acts as a two-way regulator of matrix Ca2+, so a regulatory rather
    than transporting role in Ca2+ handling remains plausible. Do not treat this
    group as established mechanism for the human disease.
  evidence:
  - reference: PMID:19797662
    reference_title: "Genome-wide RNAi screen identifies Letm1 as a mitochondrial Ca2+/H+ antiporter."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "RNAi knockdown, overexpression, and liposome reconstitution of the purified Letm1 protein demonstrate that Letm1 is a mitochondrial Ca2+/H+ antiporter."
    explanation: >-
      The primary claim that LETM1 is the Ca2+/H+ antiporter, from the screen
      and reconstitution study that originated this hypothesis.
  - reference: PMID:36321428
    reference_title: "TMBIM5 is the Ca(2+) /H(+) antiporter of mammalian mitochondria."
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: "Taken together, we demonstrate that TMBIM5, but not LETM1, is the long-sought mitochondrial CHE, involved in setting and regulating the mitochondrial proton gradient."
    explanation: >-
      Directly contradicts the Ca2+/H+ antiporter assignment for LETM1,
      attributing that activity to its interactor TMBIM5 instead.

pathophysiology:
- name: Biallelic LETM1 Loss of Function
  biological_scale: MOLECULAR
  role: initiator
  mechanism_confidence: ESTABLISHED
  description: >-
    Two variant LETM1 alleles reduce or abolish the function of the inner
    mitochondrial membrane osmoregulator. LETM1 is a single-transmembrane
    protein of the SLC55 family with a large matrix-facing C-terminal domain
    carrying coiled-coil and EF-hand-like motifs, and it assembles into a
    high-molecular-weight complex. Missense, frameshift, stop-loss and
    splice-region alleles are all reported; the yeast complementation assay
    distinguished disease alleles from rare benign LETM1 variants.
  molecular_functions:
  - preferred_term: LETM1 potassium/proton antiporter activity
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0015386
      label: potassium:proton antiporter activity
  genetic_context:
    functional_impact_category: LOSS_OF_FUNCTION
    zygosity: HOMOZYGOUS
    variant_origin: GERMLINE
  downstream:
  - target: Defective Mitochondrial K+/H+ Exchange
    causal_link_type: DIRECT
    hypothesis_groups:
    - letm1_k_h_exchange
    description: >-
      Loss of LETM1 removes the transport activity that couples K+ efflux to H+
      entry across the inner membrane.
    evidence:
    - reference: PMID:36055214
      reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Collectively, our results demonstrate that bi-allelic pathogenic LETM1 variants are associated with defective mitochondrial K+ efflux, swollen mitochondrial matrix structures, and a reduction in proteins levels and activity of the electron transfer chain."
      explanation: >-
        Ties the patients' bi-allelic variants directly to loss of mitochondrial
        K+ efflux in their own cells, which is this edge.
  - target: Perturbed Mitochondrial Calcium Handling
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - letm1_ca_h_exchange
    description: >-
      A contested second arm. Whether loss of LETM1 disturbs matrix Ca2+ by
      removing a Ca2+/H+ antiporter, by removing a regulator of one, or only
      indirectly through the collapse of the H+ gradient, is unresolved - see
      the `letm1_ca_h_exchange` hypothesis group and the transport-identity
      controversy in `discussions`.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) (MIM: 604407) is a ubiquitously expressed and phylogenetically highly conserved nuclear gene."
    explanation: >-
      Establishes LETM1 as a ubiquitously expressed conserved nuclear gene,
      which is why its loss produces multisystem rather than tissue-restricted
      disease.

- name: Defective Mitochondrial K+/H+ Exchange
  biological_scale: MOLECULAR
  role: effector
  mechanism_confidence: ESTABLISHED
  description: >-
    Mitochondrial K+/H+ exchange is electroneutral and obligatorily coupled: a
    K+ gradient drives H+ against its own concentration gradient and vice versa.
    This activity is what normally offsets the electrophoretic K+ influx driven
    by the inner membrane potential, and so sets matrix volume. In LETM1
    deficiency the exchange fails and K+ efflux is lost.
  biological_processes:
  - preferred_term: mitochondrial potassium ion transmembrane transport
    modifier: DECREASED
    term:
      id: GO:0071805
      label: potassium ion transmembrane transport
  - preferred_term: coupled proton transport across the inner mitochondrial membrane
    modifier: DECREASED
    term:
      id: GO:1902600
      label: proton transmembrane transport
  downstream:
  - target: Mitochondrial Matrix Swelling and Cristae Disorganization
    causal_link_type: DIRECT
    description: >-
      Without compensating K+ efflux, electrophoretic K+ uptake is unopposed and
      water follows osmotically into the matrix.
    evidence:
    - reference: PMID:36055214
      reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Impaired KHE activity in LETM1-deficient cells leads to uncompensated electrophoretic K+ uptake and consequent mitochondrial swelling."
      explanation: >-
        States the causal step from impaired exchange to swelling explicitly.
  - target: Mitochondrial Membrane Potential Depolarization
    causal_link_type: DIRECT
    description: >-
      Proband fibroblasts showed an irregular, reduced polarization pattern that
      was corrected by the synthetic K+/H+ exchanger nigericin, indicating the
      depolarization is downstream of the lost exchange activity rather than an
      independent lesion.
    evidence:
    - reference: PMID:36055214
      reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Treatment with the synthetic KHE nigericin to counteract the loss of K+ homeostasis reverted the decreased membrane potential to control levels in F10 and F5"
      explanation: >-
        Pharmacological restoration of K+/H+ exchange rescues the membrane
        potential, which is the causal test for this edge.
  evidence:
  - reference: PMID:15904662
    reference_title: "Electroneutral K+/H+ exchange in mitochondrial membrane vesicles involves Yol027/Letm1 proteins."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "K+ and H+ translocations have stoichiometries similar to those mediated by the exogenous K+/H+ exchanger nigericin, and they are shown to be essentially electroneutral and obligatorily coupled."
    explanation: >-
      Characterises the exchange activity that is lost, establishing it as
      electroneutral and obligatorily coupled.

- name: Perturbed Mitochondrial Calcium Handling
  biological_scale: MOLECULAR
  role: modifier
  mechanism_confidence: HYPOTHETICAL
  description: >-
    Contested arm, curated because the literature is genuinely divided rather
    than because the mechanism is established for this disease. Letm1 knockdown
    reduces mitochondrial Ca2+ uptake and H+ extrusion and impairs ATP
    generation, and the LETM1 F-EF-hand is a bidirectional regulator of matrix
    Ca2+; but the Na+-independent mitochondrial Ca2+/H+ exchanger has since been
    attributed to TMBIM5 rather than LETM1. The delineating human study assayed
    K+/H+ exchange, not Ca2+ flux, in proband material, so no patient-level
    evidence bears on this node - it rests entirely on model and in vitro
    systems.
  biological_processes:
  - preferred_term: mitochondrial calcium ion homeostasis
    modifier: DYSREGULATED
    term:
      id: GO:0051560
      label: mitochondrial calcium ion homeostasis
  downstream:
  - target: Cellular Energy Failure in High-Demand Tissues
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - letm1_ca_h_exchange
    description: >-
      Matrix Ca2+ tunes the rate-limiting dehydrogenases of the TCA cycle, so
      disturbed Ca2+ handling would reduce ATP output independently of the
      structural respiratory chain defect. Demonstrated only in knockdown cells
      and heterozygous mice.
    evidence:
    - reference: PMID:23716663
      reference_title: "Letm1, the mitochondrial Ca2+/H+ antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Cellular Letm1 knockdown reduced Ca(2+)mito uptake, H(+)mito extrusion and impaired mitochondrial ATP generation capacity."
      explanation: >-
        Links reduced mitochondrial Ca2+ handling after Letm1 knockdown to
        impaired ATP generation, which is this edge - in cells, not patients.
  evidence:
  - reference: PMID:39317198
    reference_title: "An AI-informed NMR structure reveals an extraordinary LETM1 F-EF-hand domain that functions as a two-way regulator of mitochondrial calcium."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Functionally, mutations that augmented or weakened Ca2+ binding increased or decreased matrix Ca2+, respectively, establishing F-EF as a two-way mitochondrial Ca2+ regulator."
    explanation: >-
      Structural and mutational evidence that the LETM1 EF-hand regulates matrix
      Ca2+ in both directions, supporting a Ca2+-regulatory role even if LETM1
      is not itself the Ca2+/H+ exchanger.
  - reference: PMID:29123128
    reference_title: "PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our findings delineate a mechanism by which PINK1 regulates mitochondrial Ca2+ level through LETM1 and suggest a model by which PINK1 loss leads to deficient phosphorylation of LETM1 and impaired mitochondrial Ca2+ transport."
    explanation: >-
      Places LETM1 downstream of PINK1 in mitochondrial Ca2+ regulation in
      neurons, which is the most direct link between LETM1 Ca2+ handling and
      neuronal vulnerability - though shown in a Parkinson-disease model system,
      not in LETM1-variant patient cells.

- name: Mitochondrial Matrix Swelling and Cristae Disorganization
  biological_scale: CELLULAR
  role: effector
  mechanism_confidence: ESTABLISHED
  description: >-
    The pathological hallmark of LETM1 depletion across every organism studied:
    the matrix swells and becomes less electron-dense, cristae are lost, and the
    network fragments into donut segments, punctate units and enlarged bodies
    separated from the main network. Transmission electron microscopy of
    fibroblasts from two probands reproduced this directly. The reciprocal
    experiment is informative - LETM1 overexpression condenses the matrix and
    swells cristae - confirming that LETM1 dosage sets matrix volume in both
    directions.
  cell_types:
  - preferred_term: patient-derived dermal fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  biological_processes:
  - preferred_term: cristae formation
    modifier: DECREASED
    term:
      id: GO:0042407
      label: cristae formation
  - preferred_term: mitochondrion organization
    modifier: ABNORMAL
    term:
      id: GO:0007005
      label: mitochondrion organization
  - preferred_term: mitochondrial matrix volume homeostasis
    modifier: ABNORMAL
    description: >-
      Deliberately left unbound. NTR candidate - GO has no term for maintenance
      of mitochondrial matrix volume. The obvious candidate, GO:0006884 cell
      volume homeostasis, is defined over "the three-dimensional space occupied
      by a cell", is_a GO:0008361 regulation of cell size, and carries
      RO:0019000 some OBA:0000056 cell volume, so it is a cell-scope term on an
      organelle-scope claim; searches of GO for mitochondrial volume,
      mitochondrion volume, organelle volume and mitochondrial swelling return
      nothing. No term beats a wrong-scope one, and the two bound processes on
      this node - GO:0007005 mitochondrion organization and GO:0042407 cristae
      formation - already carry the mechanistic claim.
  downstream:
  - target: Respiratory Chain Complex Deficiency
    causal_link_type: DIRECT
    description: >-
      Loss of cristae architecture destabilises the respiratory chain complexes
      that the cristae membranes house. LETM1 knockdown impairs respiratory
      chain complex formation, and the swelling is not simply a consequence of
      respiratory chain loss - cells without mitochondrial DNA lose active
      respiratory chains yet keep tubular networks.
    evidence:
    - reference: PMID:18628306
      reference_title: "Characterization of the mitochondrial protein LETM1, which maintains the mitochondrial tubular shapes and interacts with the AAA-ATPase BCS1L."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "LETM1 downregulation caused mitochondrial swelling and cristae disorganization, but seemed to have little effect on membrane fusion and fission. Formation of the respiratory-chain complex was impaired by LETM1 knockdown."
      explanation: >-
        Establishes the direction of this edge - LETM1 loss produces both the
        morphological lesion and impaired respiratory chain assembly.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "LETM1 variants cause swollen mitochondria and loss of cristae. The ultrastructure of control (C1) and affected individual (F5 and F10) fibroblasts was investigated by transmission electron microscopy"
    explanation: >-
      Demonstrates the swelling and cristae loss in fibroblasts from affected
      individuals carrying the disease variants, not only in knockdown models.
  - reference: PMID:17606466
    reference_title: "Inverse correlation between expression of the Wolfs Hirschhorn candidate gene Letm1 and mitochondrial volume in C. elegans and in mammalian cells."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The opposite effect is achieved by overexpression of Letm1. Overexpression increases the electron density of the mitochondrial matrix and swelling of cristae."
    explanation: >-
      The reciprocal dosage experiment, performed in the cultured mammalian
      cells that are this study's cell-based arm - raising Letm1 condenses the
      matrix instead of swelling it. Establishes that Letm1 sets matrix volume
      in both directions rather than being permissive for it.
  - reference: PMID:17606466
    reference_title: "Inverse correlation between expression of the Wolfs Hirschhorn candidate gene Letm1 and mitochondrial volume in C. elegans and in mammalian cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "in C. elegans lead to swellings along the lengths of mitochondria, consistent with the phenotype observed in yeast."
    explanation: >-
      The whole-organism arm of the same study - a C. elegans letm-1 mutant
      reproduces the swelling seen in cell culture, so the lesion is conserved
      rather than an artefact of cultured cells. Quoted as a partial sentence
      because the source states the human-cell and C. elegans results in one
      sentence, and this item is graded for the animal result alone.
  - reference: PMID:32139798
    reference_title: "The mitochondrial inner membrane protein LETM1 modulates cristae organization through its LETM domain."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "LETM1 mutant proteins with alanine substitutions fail to facilitate the formation of invaginated membrane structures, suggesting that LETM1 plays a fundamental role in the organization of mitochondrial membrane morphology."
    explanation: >-
      Reconstitution in proteoliposomes shows LETM1 shapes membranes into
      invaginations directly, so cristae disorganization is a proximal
      consequence of losing the protein rather than only a downstream effect of
      osmotic swelling.

- name: Mitochondrial Membrane Potential Depolarization
  biological_scale: CELLULAR
  role: effector
  mechanism_confidence: PROVISIONAL
  description: >-
    Proband fibroblasts showed an irregular polarization pattern by
    membrane-potential-dependent dye, with reduced potential in two families.
    Nigericin restored it; ketone bodies did not, although ketone bodies did
    restore elongated mitochondrial shapes. The dissociation is informative -
    it separates the osmotic/potential lesion from the morphological one.
  biological_processes:
  - preferred_term: regulation of mitochondrial membrane potential
    modifier: DECREASED
    term:
      id: GO:0051881
      label: regulation of mitochondrial membrane potential
  downstream:
  - target: Respiratory Chain Complex Deficiency
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      A reduced protonmotive force lowers the thermodynamic driving force for
      oxidative phosphorylation and compounds the structural complex deficiency.

- name: Respiratory Chain Complex Deficiency
  biological_scale: CELLULAR
  role: effector
  mechanism_confidence: ESTABLISHED
  conforms_to: "mitochondrial_dysfunction#Bioenergetic Decline and Oxidative Stress"
  description: >-
    Every affected individual in the delineating cohort had a respiratory chain
    complex deficiency - the only feature present in 100% of the cohort. Proband
    fibroblasts and muscle showed reduced levels and activity of electron
    transfer chain proteins, consistent with the loss of cristae architecture
    that houses them.

    Conformance note: this node conforms to the module's central bioenergetic
    node only in part. The module pairs decreased oxidative phosphorylation with
    increased reactive oxygen species; decreased oxidative phosphorylation is
    directly evidenced in these patients, whereas no ROS measurement is reported
    in the LETM1 cohort and none is asserted here. The module's upstream node -
    age-related mitochondrial damage and somatic mtDNA mutation - does not apply
    to a childhood-onset primary nuclear-gene defect, which is why conformance
    is declared at this node alone and not along the module's whole chain.
  biological_processes:
  - preferred_term: oxidative phosphorylation
    modifier: DECREASED
    term:
      id: GO:0006119
      label: oxidative phosphorylation
  - preferred_term: mitochondrial respiratory chain complex assembly
    modifier: DECREASED
    term:
      id: GO:0033108
      label: mitochondrial respiratory chain complex assembly
  downstream:
  - target: Cellular Energy Failure in High-Demand Tissues
    causal_link_type: DIRECT
    description: >-
      Reduced electron transfer chain content and activity lowers ATP supply,
      which is limiting first in the tissues with the highest oxidative demand.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The common features included respiratory chain complex deficiencies (100%), global developmental delay (94%), optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%)"
    explanation: >-
      Respiratory chain complex deficiency was present in every affected
      individual, making it the obligate biochemical consequence of the lesion.

- name: Cellular Energy Failure in High-Demand Tissues
  biological_scale: TISSUE
  role: effector
  mechanism_confidence: PROVISIONAL
  description: >-
    ATP supply falls below demand preferentially in the tissues with the highest
    and least interruptible oxidative requirement - retinal ganglion cells and
    their long unmyelinated axons, cochlear hair cells, cerebellar Purkinje
    cells, cortical neurons, cardiomyocytes, skeletal muscle and pancreatic beta
    cells. This tissue-selectivity, from a defect in a ubiquitously expressed
    gene, is the standard explanation for the organ pattern of mitochondrial
    disease; here it is inferred from that general principle plus the observed
    organ involvement rather than measured tissue by tissue, hence PROVISIONAL.
    Elevated serum lactate in 8 of 12 tested individuals is the systemic
    correlate.
  cell_types:
  - preferred_term: retinal ganglion cell
    term:
      id: CL:0000740
      label: retinal ganglion cell
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  - preferred_term: cerebellar Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
  - preferred_term: cardiomyocyte
    term:
      id: CL:0000746
      label: cardiac muscle cell
  - preferred_term: skeletal muscle fiber
    term:
      id: CL:0008002
      label: skeletal muscle fiber
  - preferred_term: pancreatic beta cell
    term:
      id: CL:0000169
      label: type B pancreatic cell
  biological_processes:
  - preferred_term: ATP synthesis coupled electron transport
    modifier: DECREASED
    term:
      id: GO:0042773
      label: ATP synthesis coupled electron transport
  downstream:
  - target: Progressive Neurodegeneration and Multisystem Involvement
    causal_link_type: DIRECT
  - target: Cardiomyopathy
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Myopathy
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Muscular Wasting
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Wasting follows the same energy-failure route as the myopathy, with the
      neurogenic component seen on nerve conduction studies as an additional
      intermediate.
  - target: Diabetes Mellitus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Elevated serum lactate was confirmed in 8/12 (67%) affected individuals."
    explanation: >-
      Systemic lactate elevation is the biochemical signature of a shift to
      anaerobic metabolism when oxidative ATP supply is insufficient.

- name: Progressive Neurodegeneration and Multisystem Involvement
  biological_scale: ORGANISM
  role: outcome
  mechanism_confidence: ESTABLISHED
  description: >-
    Sustained energy failure in post-mitotic, high-demand neural tissue produces
    a variably progressive neurodegenerative course rather than a static
    encephalopathy: developmental regression, loss of ambulation, cerebellar and
    pontine atrophy, and optic nerve and chiasmal atrophy on imaging. Onset
    ranges from birth to 8 years, and the rate of progression is heterogeneous
    across families.
  biological_processes:
  - preferred_term: neuron apoptotic process
    modifier: INCREASED
    term:
      id: GO:0051402
      label: neuron apoptotic process
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  downstream:
  - target: Global Developmental Delay
    causal_link_type: DIRECT
  - target: Optic Atrophy
    causal_link_type: DIRECT
  - target: Sensorineural Hearing Loss
    causal_link_type: DIRECT
  - target: Cerebellar Ataxia
    causal_link_type: DIRECT
  - target: Epilepsy
    causal_link_type: DIRECT
  - target: Spasticity
    causal_link_type: DIRECT
  - target: Developmental Regression
    causal_link_type: DIRECT
  - target: Loss of Ambulation
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      The functional endpoint of the regression, reached through the combined
      corticospinal and cerebellar motor lesions rather than directly.
  - target: Cerebellar Atrophy
    causal_link_type: DIRECT
  - target: Pontine Hypoplasia
    causal_link_type: DIRECT
    description: >-
      The pontine lesion is reported in the same infratentorial imaging
      description as the cerebellar atrophy and in the same proband, so it is
      wired from the same node.
  - target: Spastic-Ataxic Gait
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      The gait is the functional convergence of the separately wired
      corticospinal (spasticity) and cerebellar (ataxia) lesions.
  - target: Impaired Speech Acquisition
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Mediated by the sensorineural hearing loss, with a motor-speech
      contribution from the spastic dysarthria recorded in the cohort.
  - target: Cataract
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Hypotonia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These manifested as a spectrum of predominantly infantile-onset (14/18, 78%) and variably progressive neurological, metabolic, and dysmorphic symptoms, plus multiple organ dysfunction associated with neurodegeneration."
    explanation: >-
      Characterises the clinical outcome as infantile-onset, progressive and
      multisystem with neurodegeneration, which is this node.

phenotypes:
- category: Neurologic
  name: Global Developmental Delay
  frequency: VERY_FREQUENT
  description: >-
    Present in 94% of the cohort. Global developmental delay or intellectual
    disability was recorded in all but one affected individual.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The common features included respiratory chain complex deficiencies (100%), global developmental delay (94%), optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%)"
    explanation: Reports global developmental delay in 94% of affected individuals.

- category: Ophthalmologic
  name: Optic Atrophy
  frequency: VERY_FREQUENT
  description: >-
    Bilateral optic atrophy with impaired vision in 83% of the cohort. Imaging
    showed severe optic nerve and chiasmal atrophy in affected individuals, and
    photographed probands all wore glasses for bilateral optic atrophy.
  phenotype_term:
    preferred_term: Optic atrophy
    term:
      id: HP:0000648
      label: Optic atrophy
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In (iii) arrowheads point at the severe optic nerve and chiasm atrophy in 2 different individuals"
    explanation: >-
      Neuroimaging confirmation of optic nerve and chiasmal atrophy, the
      structural correlate of the clinical optic atrophy.

- category: Otologic
  name: Sensorineural Hearing Loss
  frequency: FREQUENT
  description: Sensorineural deafness in 78% of the cohort.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"
    explanation: Reports sensorineural hearing loss in 78% of affected individuals.

- category: Neurologic
  name: Cerebellar Ataxia
  frequency: FREQUENT
  description: >-
    Cerebellar ataxia in 78% of the cohort, with cerebellar atrophy or vermian
    hypoplasia on imaging in a subset.
  phenotype_term:
    preferred_term: Cerebellar ataxia
    term:
      id: HP:0001251
      label: Ataxia
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "optic atrophy (83%), sensorineural hearing loss (78%), and cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"
    explanation: Reports cerebellar ataxia in 78% of affected individuals.

- category: Musculoskeletal
  name: Muscular Wasting
  frequency: FREQUENT
  description: >-
    Muscular wasting in 7 of 10 assessed individuals (70%), the most common of
    the neuromuscular features and more frequent than the myopathy tabulated
    separately at 50%. Curated as a distinct phenotype rather than folded into
    `Myopathy` because the source tabulates the two as separate Table 2 rows
    with different denominators, and because the wasting is concordant with the
    neurogenic changes on nerve conduction studies as well as with the
    myopathic ones - it is not simply the visible expression of the myopathy.
  phenotype_term:
    preferred_term: Muscular wasting
    term:
      id: HP:0003202
      label: Skeletal muscle atrophy
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "spasticity (8/15, 53%), hypotonia (11/18, 61%), muscular wasting (7/10, 70%), and cerebellar ataxia (7/9, 78%)"
    explanation: >-
      Reports muscular wasting in 70% of the individuals in whom it was
      assessed, the highest-frequency neuromuscular feature in the cohort.

- category: Neurologic
  name: Epilepsy
  frequency: FREQUENT
  description: >-
    Epilepsy in 67% of the cohort. Note that seizure susceptibility is the
    phenotype for which LETM1 was historically proposed as the Wolf-Hirschhorn
    candidate gene; here it arises from bi-allelic loss, not from 4p16.3
    hemizygosity.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"
    explanation: Reports epilepsy in 67% of affected individuals.

- category: Neurologic
  name: Impaired Speech Acquisition
  frequency: FREQUENT
  description: >-
    Impaired speech acquisition in 6 of 9 assessed individuals (67%). Curated
    separately from the global developmental delay because the cohort's
    sensorineural hearing loss (78%) gives it a specific and partly remediable
    mechanism - hearing aids were fitted in 7 of 10 individuals with hearing
    loss - so the speech deficit is not simply the language component of the
    general delay. One photographed proband is recorded as spastic-dysarthric,
    indicating a motor-speech contribution as well.
  phenotype_term:
    preferred_term: Impaired speech acquisition
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "impaired speech acquisition (6/9, 67%) were among the common neurodevelopmental symptoms"
    explanation: >-
      Reports impaired speech acquisition in 67% of the individuals in whom it
      was assessed, as a common neurodevelopmental symptom of the cohort.

- category: Neurologic
  name: Spasticity
  frequency: FREQUENT
  description: Spasticity or hypertonia in 53% of the cohort.
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "epilepsy (67%), spasticity (53%), and myopathy (50%)"
    explanation: Reports spasticity in 53% of affected individuals.

- category: Musculoskeletal
  name: Myopathy
  frequency: FREQUENT
  description: >-
    Myopathy in 50% of the cohort. Electromyography and nerve conduction studies
    available from five individuals showed neurogenic changes in three of five
    and myopathic changes in two of four, so the neuromuscular involvement is
    mixed rather than purely myopathic.
  phenotype_term:
    preferred_term: Myopathy
    term:
      id: HP:0003198
      label: Myopathy
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hence, electromyography and nerve conductions studies available from 5 individuals showed neurogenic (3/5) and myopathic changes (2/4)."
    explanation: >-
      Documents the electrophysiological basis of the myopathy, and shows the
      neuromuscular picture includes a neurogenic component.

- category: Ophthalmologic
  name: Cataract
  frequency: FREQUENT
  description: Bilateral cataracts in 42% of the cohort.
  phenotype_term:
    preferred_term: Bilateral cataract
    term:
      id: HP:0000518
      label: Cataract
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other features included bilateral cataracts (42%), cardiomyopathy (36%), and diabetes (27%)."
    explanation: Reports bilateral cataracts in 42% of affected individuals.

- category: Cardiovascular
  name: Cardiomyopathy
  frequency: FREQUENT
  description: Cardiomyopathy in 36% of the cohort.
  phenotype_term:
    preferred_term: Cardiomyopathy
    term:
      id: HP:0001638
      label: Cardiomyopathy
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other features included bilateral cataracts (42%), cardiomyopathy (36%), and diabetes (27%)."
    explanation: Reports cardiomyopathy in 36% of affected individuals.

- category: Endocrine
  name: Diabetes Mellitus
  frequency: OCCASIONAL
  description: >-
    Diabetes in 27% of the cohort - a recognised feature of mitochondrial
    disease, attributed to the high oxidative demand of insulin secretion.
  phenotype_term:
    preferred_term: Diabetes mellitus
    term:
      id: HP:0000819
      label: Diabetes mellitus
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other features included bilateral cataracts (42%), cardiomyopathy (36%), and diabetes (27%)."
    explanation: Reports diabetes in 27% of affected individuals.

- category: Neurologic
  name: Developmental Regression
  frequency: FREQUENT
  description: >-
    Loss of previously acquired skills was recorded in 9/13 (69%) of the cohort
    and is the feature that
    makes this a neurodegenerative rather than a purely neurodevelopmental
    disorder. The authors publish that fraction themselves, so the incomplete
    per-individual tabulation is already accounted for by the 13 denominator;
    69% sits in the HPO FREQUENT band.
  phenotype_term:
    preferred_term: Developmental regression
    term:
      id: HP:0002376
      label: Developmental regression
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Developmental regression was later present in 9/13 (69%) affected individuals"
    explanation: >-
      States the phenotype and its cohort fraction directly, which is both the
      basis for the FREQUENT band and a direct rather than inferred support for
      the phenotype itself.

- category: Neurologic
  name: Loss of Ambulation
  description: >-
    Loss of independent ambulation at a mean age of 5.4 years (range 2-12),
    the functional endpoint of the regression and the point at which the
    spastic-ataxic gait ceases to be compensable. Promoted to its own phenotype
    rather than left as prose inside `Developmental Regression` because it is
    separately tabulated per individual with its own age of onset. Frequency is
    deliberately omitted - the source states a mean age and range for those who
    lost ambulation, and the Table 2 row carries several "no data" entries, so
    no cohort percentage can be read off it.
  phenotype_term:
    preferred_term: Loss of ambulation
    term:
      id: HP:0002505
      label: Loss of ambulation
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with loss of independent ambulation by a mean age of 5.4 ± 3.2 years (range 2–12)"
    explanation: >-
      Reports loss of independent ambulation and the age at which it occurred
      across the cohort.

- category: Neurologic
  name: Cerebellar Atrophy
  description: >-
    Severe cerebellar atrophy with pontine hypoplasia in one proband, and only
    mild vermian hypoplasia in another - the imaging severity varies
    considerably across the cohort. Brain MRI was available for six affected
    individuals.
  phenotype_term:
    preferred_term: Cerebellar atrophy
    term:
      id: HP:0001272
      label: Cerebellar atrophy
  diagnostic: true
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "severe cerebellar atrophy (arrows) and pontine hypoplasia (arrowheads) are shown, while in (ii) (F6:S1), only mild vermian hypoplasia is noted"
    explanation: >-
      Reports the cerebellar imaging findings and their range of severity across
      the cohort.

- category: Neurologic
  name: Hypotonia
  frequency: FREQUENT
  description: >-
    Central hypotonia in 11 of 18 individuals (61%), frequently the presenting
    sign in the infantile-onset individuals, often preceding or coexisting with
    later spasticity.
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "spasticity (8/15, 53%), hypotonia (11/18, 61%), muscular wasting (7/10, 70%), and cerebellar ataxia (7/9, 78%)"
    explanation: >-
      Reports central hypotonia in 61% of the cohort, the denominator for this
      frequency.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These manifested as a spectrum of predominantly infantile-onset (14/18, 78%) and variably progressive neurological, metabolic, and dysmorphic symptoms"
    explanation: >-
      Establishes the infantile-onset neurological spectrum in which hypotonia
      is tabulated as a presenting feature.

- category: Ophthalmologic
  name: Nystagmus
  frequency: FREQUENT
  description: >-
    Nystagmus in 7 of 13 assessed individuals (54%), making it one of the more
    common features of the disease. It sits alongside the optic atrophy as the
    second ophthalmologic manifestation, but is a distinct finding - an
    oculomotor abnormality attributable to the brainstem and cerebellar
    involvement rather than to the anterior visual pathway lesion.
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other frequent neurological symptoms were nystagmus (7/13, 54%)"
    explanation: Reports nystagmus in 54% of the individuals in whom it was assessed.

- category: Neurologic
  name: Hyperkinetic Movement Disorders
  frequency: FREQUENT
  description: >-
    Hyperkinetic movements in 4 of 12 assessed individuals (33%). Independently
    highlighted in the source discussion as one of the features that mark this
    as an archetypal mitochondrial disorder rather than Wolf-Hirschhorn
    syndrome, so it carries differential-diagnostic weight beyond its frequency.
  phenotype_term:
    preferred_term: Hyperkinetic movement disorders
    term:
      id: HP:0002487
      label: Hyperkinetic movements
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "myopathy (6/12, 50%), hyperkinetic movement disorders (4/12, 33%)"
    explanation: >-
      Reports hyperkinetic movement disorders in 33% of the individuals in whom
      they were assessed.

- category: Neurologic
  name: Spastic-Ataxic Gait
  frequency: FREQUENT
  description: >-
    A combined spastic and ataxic gait in 3 of 9 assessed individuals (33%),
    described as progressive in the source discussion. The gait is the
    functional convergence of the two separately tabulated motor lesions -
    corticospinal (spasticity) and cerebellar (ataxia) - and precedes the loss
    of independent ambulation recorded at a mean of 5.4 years.
  phenotype_term:
    preferred_term: Spastic-ataxic gait
    term:
      id: HP:0002497
      label: Spastic ataxia
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hyperkinetic movement disorders (4/12, 33%), and spastic-ataxic gait (3/9, 33%)"
    explanation: >-
      Reports spastic-ataxic gait in 33% of the individuals in whom gait was
      assessed.

- category: Neurologic
  name: Hyperreflexia
  frequency: FREQUENT
  description: >-
    Brisk deep tendon reflexes in 4 of 10 assessed individuals (40%). Together
    with the extensor plantar responses this is the examination evidence of
    corticospinal tract involvement, and is what makes the pyramidal component
    of the disease an observation rather than an inference from the spasticity
    alone.
  phenotype_term:
    preferred_term: Brisk deep tendon reflexes
    term:
      id: HP:0001347
      label: Hyperreflexia
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "combined with brisk deep tendon reflexes (4/10, 40%)"
    explanation: >-
      Reports brisk deep tendon reflexes in 40% of the individuals in whom
      reflexes were assessed.

- category: Neurologic
  name: Extensor Plantar Response
  frequency: FREQUENT
  description: >-
    Upgoing plantar responses in 4 of 9 assessed individuals (44%). The second
    pyramidal sign, and the more specific of the two - an extensor plantar
    response localises the lesion to the corticospinal tract in a way that brisk
    reflexes alone do not.
  phenotype_term:
    preferred_term: Upgoing plantar response
    term:
      id: HP:0003487
      label: Babinski sign
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "brisk deep tendon reflexes (4/10, 40%), upgoing plantar response (4/9, 44%)"
    explanation: >-
      Reports upgoing plantar responses in 44% of the individuals in whom
      plantar responses were assessed.

- category: Neurologic
  name: Peripheral Neuropathy
  frequency: FREQUENT
  description: >-
    Peripheral neuropathy in 3 of 9 assessed individuals (33%). Concordant with
    the nerve conduction studies, which showed neurogenic changes in 3 of 5
    individuals tested - so the neuromuscular involvement in this disease is
    mixed neurogenic and myopathic rather than purely myopathic.
  phenotype_term:
    preferred_term: Peripheral neuropathy
    term:
      id: HP:0009830
      label: Peripheral neuropathy
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "upgoing plantar response (4/9, 44%), and peripheral neuropathy (3/9, 33%)."
    explanation: >-
      Reports peripheral neuropathy in 33% of the individuals in whom it was
      assessed.

- category: Growth
  name: Failure to Thrive
  description: >-
    Named as one of the common presenting symptoms of the cohort. Frequency is
    deliberately omitted - the source lists this among the presenting symptoms
    without a denominator, and the related Table 2 row ("small weight and
    height") is tabulated per individual with several "no data" entries, so no
    cohort percentage can be read off the source.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The common presenting symptoms were global developmental delay, cognitive and motor regression, failure to thrive, central hypotonia, respiratory distress, and feeding difficulties."
    explanation: >-
      Lists failure to thrive among the common presenting symptoms of the
      cohort.

- category: Gastrointestinal
  name: Feeding Difficulties
  description: >-
    Named as one of the common presenting symptoms, and among the reasons for
    special care baby unit admission in the neonatal period. Frequency is
    deliberately omitted for the same reason as failure to thrive - the source
    gives no denominator for the presenting-symptom list.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The common presenting symptoms were global developmental delay, cognitive and motor regression, failure to thrive, central hypotonia, respiratory distress, and feeding difficulties."
    explanation: >-
      Lists feeding difficulties among the common presenting symptoms of the
      cohort.

- category: Respiratory
  name: Respiratory Distress
  description: >-
    Named as one of the common presenting symptoms, and among the reasons for
    special care baby unit admission in 33% of the cohort during the neonatal
    period. Frequency is deliberately omitted - the source gives no denominator
    for the presenting-symptom list, and the 33% figure is the admission rate
    for respiratory, cardiac and feeding issues combined, not for respiratory
    distress alone.
  phenotype_term:
    preferred_term: Respiratory distress
    term:
      id: HP:0002098
      label: Respiratory distress
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The common presenting symptoms were global developmental delay, cognitive and motor regression, failure to thrive, central hypotonia, respiratory distress, and feeding difficulties."
    explanation: >-
      Lists respiratory distress among the common presenting symptoms of the
      cohort.

- category: Metabolic
  name: Mitochondrial Respiratory Chain Defect
  frequency: OBLIGATE
  description: >-
    A respiratory chain complex deficiency was demonstrated in every affected
    individual assessed - the single most consistent finding in the cohort and
    the biochemical basis for classifying this as a primary mitochondrial
    disease.
  phenotype_term:
    preferred_term: Mitochondrial respiratory chain defects
    term:
      id: HP:0200125
      label: Mitochondrial respiratory chain defects
  diagnostic: true
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The common features included respiratory chain complex deficiencies (100%)"
    explanation: >-
      Respiratory chain complex deficiency was present in 100% of the cohort,
      supporting an obligate frequency.

- category: Musculoskeletal
  name: Cytochrome C Oxidase-Negative Muscle Fibers
  description: >-
    Muscle biopsy was available from 7 individuals and abnormal in 5.
    COX-deficient fibers were the recurring finding, appearing in four separate
    individuals, alongside internal nuclei, lipid deposition and type I fiber
    predominance. This is the tissue-level counterpart of the respiratory chain
    deficiency measured biochemically.
  phenotype_term:
    preferred_term: Cytochrome C oxidase-negative muscle fibers
    term:
      id: HP:0003688
      label: Cytochrome C oxidase-negative muscle fibers
  diagnostic: true
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Muscle biopsy was available from 7 persons and of these, 5 had abnormal findings including scattered necrotic and regenerating COX-deficient fibers with an excess of internal nuclei"
    explanation: >-
      Documents COX-deficient fibers on muscle biopsy and the fraction of
      biopsied individuals with abnormal histology.

- category: Musculoskeletal
  name: Ragged-Red Muscle Fibers
  description: >-
    Reported in a single individual (F8:S1), together with COX deficiency and
    increased fiber unisometry. Recorded because ragged-red fibers are a classic
    mitochondrial myopathy finding, but this is one biopsy and not a cohort
    feature - frequency is deliberately omitted.
  phenotype_term:
    preferred_term: Ragged-red muscle fibers
    term:
      id: HP:0003200
      label: Ragged-red muscle fibers
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "COX-deficient multiple ragged-red fibers with increased fiber unisometry (F8:S1)"
    explanation: >-
      Reports ragged-red fibers in the one individual in whom they were seen.

- category: Craniofacial
  name: Facial Dysmorphism
  frequency: FREQUENT
  description: >-
    Facial dysmorphism in 4 of 10 assessed individuals (40%), comprising a long
    thin face, prominent nose, low-set ears, micrognathia, high arched palate
    and teeth abnormalities. This is a mild, non-specific and inconstant
    dysmorphic pattern rather than a recognisable gestalt, and it is the feature
    set the defining cohort describes as a milder spectrum of Wolf-Hirschhorn
    signs not previously ascribed to LETM1 - see `notes` for why that overlap
    does not make this entry Wolf-Hirschhorn syndrome.
  phenotype_term:
    preferred_term: Facial dysmorphism
    term:
      id: HP:0001999
      label: Abnormal facial shape
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"
    explanation: >-
      Gives the cohort frequency of facial dysmorphism and enumerates its
      component features.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These included thin habitus, low set ears, microcephaly, micrognathia, and low body weight."
    explanation: >-
      The discussion attributes this dysmorphic feature set to bi-allelic LETM1
      variants as a spectrum not previously ascribed to the LETM1 deletion.

- category: Craniofacial
  name: Microcephaly
  frequency: FREQUENT
  description: >-
    Occipitofrontal circumference below the third percentile in 2 of 6
    individuals in whom it was measured (33%). The source names microcephaly
    among the Wolf-Hirschhorn-like signs seen in this bi-allelic cohort, while
    attributing the microcephaly of Wolf-Hirschhorn syndrome itself to
    haploinsufficiency of WHSC1 rather than of LETM1.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Craniofacial abnormalities included occipitofrontal circumference below third percentile in 2/6 persons"
    explanation: >-
      Quantifies reduced occipitofrontal circumference in the fraction of the
      cohort in whom head circumference was measured.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It has been previously speculated that the most probable cause of growth deficiency, microcephaly, and the characteristic facial features in WHS is due to haploinsufficiency of WHSC1, a region located far from LETM1."
    explanation: >-
      Records that the microcephaly of Wolf-Hirschhorn syndrome is attributed to
      a different gene, so the microcephaly seen here is not simply the WHS
      finding recurring.

- category: Craniofacial
  name: Micrognathia
  description: >-
    Listed as a component of the cohort's facial dysmorphism and named in the
    discussion among the Wolf-Hirschhorn-like signs newly ascribed to bi-allelic
    LETM1 variants. Frequency is deliberately omitted - the source gives a
    denominator for facial dysmorphism as a whole (4/10) but none for its
    individual components, so no separate percentage can be read off it.
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"
    explanation: >-
      Names micrognathia as one of the constituent craniofacial abnormalities in
      the cohort.

- category: Craniofacial
  name: Low-Set Ears
  description: >-
    Listed as a component of the cohort's facial dysmorphism and documented
    photographically in two affected siblings from family 1. Frequency is
    deliberately omitted for the same reason as micrognathia - the source gives
    no per-feature denominator.
  phenotype_term:
    preferred_term: Low-set ears
    term:
      id: HP:0000369
      label: Low-set ears
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"
    explanation: >-
      Names low-set ears as one of the constituent craniofacial abnormalities in
      the cohort.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "F1:S1 and F1:S2 show long thin faces, low-set ears, and teeth abnormalities."
    explanation: >-
      Documents low-set ears directly in two named affected individuals.

- category: Craniofacial
  name: High Palate
  description: >-
    Listed as a component of the cohort's facial dysmorphism. Frequency is
    deliberately omitted for the same reason as micrognathia and low-set ears -
    the source gives a denominator for facial dysmorphism as a whole (4/10) but
    none for its individual components.
  phenotype_term:
    preferred_term: High arched palate
    term:
      id: HP:0000218
      label: High palate
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"
    explanation: >-
      Names a high arched palate as one of the constituent craniofacial
      abnormalities in the cohort.

- category: Craniofacial
  name: Teeth Abnormalities
  description: >-
    Listed as a component of the cohort's facial dysmorphism and documented
    photographically in two affected siblings from family 1, one of whom still
    had teeth abnormalities recorded on video assessment at 21 years.
    Frequency is deliberately omitted - the source gives no per-feature
    denominator. The binding is the general HPO dentition term because the
    source says only "teeth abnormalities" without specifying the nature of
    the dental anomaly.
  phenotype_term:
    preferred_term: Teeth abnormalities
    term:
      id: HP:0000164
      label: Abnormality of the dentition
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "facial dysmorphism (4/10, 40%) with a long thin face, prominent nose, low-set ears, micrognathia, high arched palate, and teeth abnormalities"
    explanation: >-
      Names teeth abnormalities as one of the constituent craniofacial
      abnormalities in the cohort.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "F1:S1 and F1:S2 show long thin faces, low-set ears, and teeth abnormalities."
    explanation: >-
      Documents teeth abnormalities directly in two named affected individuals.

- category: Neurologic
  name: Pontine Hypoplasia
  description: >-
    Severe pontine hypoplasia in one proband of the six affected individuals
    with reviewable brain MRI, alongside cerebellar atrophy in the same
    individual. Curated separately from `Cerebellar Atrophy` because it is a
    distinct anatomical structure. Note the source is not internally consistent
    about the nature of the pontine lesion - the text and figure legend call it
    hypoplasia, while the Table 2 abbreviation key expands the same code as
    "pontine atrophy"; HP:0012110 follows the narrative description. Frequency
    is deliberately omitted - the source describes this as a finding in "a
    proband" rather than stating a fraction.
  phenotype_term:
    preferred_term: Pontine hypoplasia
    term:
      id: HP:0012110
      label: Hypoplasia of the pons
  diagnostic: true
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Three individuals showed infratentorial abnormalities, with severe pontine hypoplasia and cerebellar atrophy in a proband from family 1 and mild vermian hypoplasia in 2 probands from family 3 and family 6."
    explanation: >-
      Reports severe pontine hypoplasia as a distinct infratentorial finding in
      the imaged subset of the cohort.

- category: Neurologic
  name: Ventriculomegaly
  description: >-
    Mild ventricular dilatation in 2 of the 6 individuals with reviewable brain
    MRI, explicitly characterised by the source as a minor and non-specific
    supratentorial finding rather than a discriminating feature. Frequency is
    deliberately omitted - the source reports a count ("2 persons each") without
    stating a fraction, and grading a finding it calls non-specific would
    overstate it.
  phenotype_term:
    preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other minor and non-specific findings were mild supratentorial atrophy and mild ventricular dilatation noted in 2 persons each."
    explanation: >-
      Reports mild ventricular dilatation and records the source's own
      characterisation of it as minor and non-specific.

- category: Cardiovascular
  name: Pericardial Effusion
  frequency: OCCASIONAL
  description: >-
    Pericardial effusion in 3 of 11 assessed individuals (27%), reported
    alongside the cardiomyopathy that is curated separately. Grouped by the
    source with the features it regards as consistent with a mitochondrial
    phenotype.
  phenotype_term:
    preferred_term: Pericardial effusion
    term:
      id: HP:0001698
      label: Pericardial effusion
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cardiomyopathy (5/14, 36%) with pericardial effusion (3/11, 27%)"
    explanation: >-
      Gives the cohort frequency of pericardial effusion and its relationship to
      the cardiomyopathy.

biochemical:
- name: Serum lactate
  biomarker_term:
    preferred_term: Increased circulating lactate concentration
    term:
      id: HP:0002151
      label: Increased circulating lactate concentration
  presence: PRESENT
  frequency: FREQUENT
  notes: >-
    Elevated in 8 of 12 tested individuals (67%). A supportive but non-specific
    marker of impaired oxidative metabolism; a normal lactate does not exclude
    the diagnosis, as a third of tested individuals had one.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Elevated serum lactate was confirmed in 8/12 (67%) affected individuals."
    explanation: Gives the frequency of lactate elevation in the tested cohort.

- name: Urine 3-methylglutaconic acid
  biomarker_term:
    preferred_term: 3-Methylglutaconic aciduria
    term:
      id: HP:0003535
      label: 3-Methylglutaconic aciduria
  presence: PRESENT
  frequency: FREQUENT
  notes: >-
    Urine organic acids were analysed in 11 affected individuals and abnormal in
    9, with 3-methylglutaconic acid excretion in 5 of 11. 3-MGA-uria is a
    recognised marker of disorders affecting the inner mitochondrial membrane
    and its cardiolipin remodelling, so its appearance here is mechanistically
    consistent with an inner-membrane osmoregulatory lesion rather than
    incidental.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Urine organic acids were analyzed in 11 affected individuals and were abnormal in 9 of them with 3-methylglutaconic acid excretion (5/11)"
    explanation: >-
      Gives the frequency of abnormal urine organic acids and specifically of
      3-methylglutaconic aciduria in the tested cohort.

- name: Plasma alanine
  biomarker_term:
    preferred_term: Elevated plasma alanine
    term:
      id: HP:0003348
      label: Hyperalaninemia
  presence: PRESENT
  frequency: OCCASIONAL
  notes: >-
    Plasma amino acids were abnormal in 4 of 9 tested, with mildly elevated
    alanine. Alanine accumulates as a transamination product of pyruvate when
    pyruvate oxidation is impaired, so it tracks the same bioenergetic lesion as
    lactate.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Plasma amino acids were abnormal in 4/9 tested with mildly elevated alanine (501–597 μmol/L, normal range 232–494)"
    explanation: >-
      Reports the frequency and magnitude of the alanine elevation with its
      reference interval.

progression:
- phase: Presentation
  age_range: Birth to 8 years; 78% (14/18) in infancy
  notes: >-
    Age at onset ranges from birth to 8 years, with 78% (14/18) presenting in
    infancy. Presenting features are typically hypotonia, developmental delay
    and visual inattention.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These manifested as a spectrum of predominantly infantile-onset (14/18, 78%)"
    explanation: Establishes infantile onset as the predominant presentation.

- phase: Progressive course
  age_range: Infancy to fourth decade
  notes: >-
    The course is heterogeneous and is explicitly classified in the source as
    slow, moderate or rapid across different families, in quantified proportions
    - rapid in 9 of 18 (50%), moderately fast in 4 of 18 (22%) and slow in 5 of
    18 (28%). Slowly progressive individuals survived into the third and fourth
    decades (35, 25, 24 and 39 years at last report), whereas rapidly
    progressive individuals died in infancy or early childhood, several before
    one year of age. Loss of ambulation occurred at 12 years, 6 years and 2.5
    years in three individuals. This spread in tempo, rather than a difference
    in mechanism, is the main axis of clinical variability and is why no
    subtypes are curated.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "and variably progressive neurological, metabolic, and dysmorphic symptoms, plus multiple organ dysfunction associated with neurodegeneration"
    explanation: >-
      The source characterises the course as variably progressive, which is what
      this phase records.
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The disease progressed rapidly in 9/18 (50%), moderately fast in 4/18 (22%), and slowly in 5/18 (28%) affected individuals."
    explanation: >-
      Quantifies the three progression tempos across the cohort, which is what
      makes the heterogeneity a measured distribution rather than an impression.

- phase: Mortality
  age_range: 2 months to 8 years in those who died
  notes: >-
    Half the reported cohort (9 of 18) died of rapidly progressing disease
    between 2 months and 8 years of age; the 9 survivors had a median age of 15
    years (range 1-39) at last follow-up. Mortality therefore tracks the
    progression tempo directly - the rapid-course group and the deceased group
    are effectively the same 50% of the cohort - so this is the outcome half of
    the tempo heterogeneity recorded in the phase above, not an independent
    axis. Numbers are from a single 18-person ascertained cohort and should not
    be read as a population survival estimate.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Half of the persons (9/18) succumbed to their rapidly progressing disease at an early age"
    explanation: >-
      Establishes that half the reported cohort died early of progressive
      disease.

treatments:
- name: Supportive and Multidisciplinary Care
  description: >-
    No disease-modifying therapy exists. Management is entirely supportive and
    follows general mitochondrial-disease practice: multidisciplinary
    surveillance for the organ systems known to be involved (vision, hearing,
    cardiac, endocrine), nutritional support, and management of the progressive
    neurological disability. This entry records the absence of targeted therapy
    honestly rather than listing speculative agents.
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: Progressive Neurodegeneration and Multisystem Involvement
    description: >-
      Symptomatic only - supportive care addresses the consequences of
      neurodegeneration and does not modify the upstream mitochondrial lesion.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "plus multiple organ dysfunction associated with neurodegeneration"
    explanation: >-
      The multiorgan involvement documented in the cohort is what makes
      multidisciplinary surveillance the appropriate management approach.

- name: Antiseizure Medication
  description: >-
    Symptomatic control of the epilepsy affecting 67% of the cohort. No
    LETM1-specific anticonvulsant strategy has been reported, and the source
    cohort does not report seizure-treatment outcomes, so no agent is
    recommended here over any other.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: anticonvulsant agent
      term:
        id: NCIT:C264
        label: Anticonvulsant Agent
  therapeutic_modality: SMALL_MOLECULE
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  target_mechanisms:
  - target: Epilepsy
    description: Symptomatic suppression of seizures without altering the mitochondrial lesion.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cerebellar ataxia (78%) followed by epilepsy (67%), spasticity (53%), and myopathy (50%)"
    explanation: >-
      Establishes epilepsy as a frequent feature of the cohort and therefore a
      target for symptomatic pharmacotherapy.

- name: Genetic Counseling
  description: >-
    Autosomal recessive inheritance with a 25% recurrence risk for siblings.
    Particularly relevant given that two-thirds of reported affected individuals
    came from consanguineous unions, where carrier testing of the extended
    family is informative.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "with 67% of the individuals (12/18) being from consanguineous unions"
    explanation: >-
      The consanguinity rate in reported families is what makes recessive
      recurrence-risk counseling and cascade carrier testing valuable.

experimental_models:
- name: Proband-derived dermal fibroblasts carrying bi-allelic LETM1 variants
  experimental_model_type: PRIMARY_CELL_CULTURE
  description: >-
    Primary fibroblasts from affected individuals in families 1, 2, 5 and 10,
    used to assay mitochondrial morphology by confocal and transmission electron
    microscopy, membrane potential, K+/H+ exchange activity and respiratory
    chain protein content. This is the highest-fidelity system available for the
    human disease because it carries the patients' own genotypes.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: dermal fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  publication: PMID:36055214
  modeled_mechanisms:
  - target: Mitochondrial Matrix Swelling and Cristae Disorganization
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Transmission electron microscopy of fibroblasts from two affected
      individuals reproduced the swollen matrix and cristae loss directly in
      patient genotype.
    limitations: >-
      Fibroblasts are not an affected tissue in this disease; the neurons,
      retinal ganglion cells and hair cells that degenerate clinically are not
      represented, and fibroblast bioenergetic demand is far lower than theirs.
    readouts:
    - name: Mitochondrial ultrastructure by transmission electron microscopy
      target: Mitochondrial Matrix Swelling and Cristae Disorganization
      direction: ALTERED
      interpretation: >-
        Swollen matrix and loss of cristae in proband fibroblasts relative to
        control.
      evidence:
      - reference: PMID:36055214
        reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "LETM1 variants cause swollen mitochondria and loss of cristae. The ultrastructure of control (C1) and affected individual (F5 and F10) fibroblasts was investigated by transmission electron microscopy"
        explanation: Reports the ultrastructural measurement behind this readout.
  - target: Mitochondrial Membrane Potential Depolarization
    relationship: MEASURES
    fidelity: MODERATE
    description: >-
      Membrane-potential-dependent dye revealed an irregular polarization
      pattern, and the nigericin rescue arm establishes the K+-handling origin
      of the depolarization.
    limitations: >-
      Reduced potential was clear in two families only, and dye-based
      measurement is semi-quantitative.
    readouts:
    - name: Mitochondrial membrane potential after nigericin
      target: Mitochondrial Membrane Potential Depolarization
      direction: RESTORED
      interpretation: >-
        The synthetic K+/H+ exchanger nigericin restored membrane potential to
        control levels, whereas ketone bodies did not.
      evidence:
      - reference: PMID:36055214
        reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "Treatment with the synthetic KHE nigericin to counteract the loss of K+ homeostasis reverted the decreased membrane potential to control levels in F10 and F5"
        explanation: Reports the rescue measurement behind this readout.

- name: Saccharomyces cerevisiae mdm38/letm1-delta complementation assay
  experimental_model_type: OTHER
  description: >-
    The yeast W303 mdm38/letm1-delta strain, which lacks the YOL027c open
    reading frame encoding the yeast LETM1 homolog, transformed with human LETM1
    carrying each candidate disease variant. Because the human protein restores
    K+/H+ exchange in this strain, the assay reads out variant function directly
    and was used to separate pathogenic alleles from rare benign LETM1 variants
    that are homozygous in gnomAD.
  organism:
    preferred_term: baker's yeast
    term:
      id: NCBITaxon:4932
      label: Saccharomyces cerevisiae
  publication: PMID:36055214
  modeled_mechanisms:
  - target: Defective Mitochondrial K+/H+ Exchange
    relationship: MEASURES
    fidelity: MODERATE
    description: >-
      Cross-species complementation quantifies the K+/H+ exchange competence of
      each human LETM1 allele.
    limitations: >-
      Yeast mitochondria lack complex I and much of the cellular context of a
      human neuron, so the assay reports transport competence of the allele and
      not the disease phenotype. Functional homology between Yol027p and human
      LETM1 is the assumption the whole assay rests on.
    evidence:
    - reference: PMID:15904662
      reference_title: "Electroneutral K+/H+ exchange in mitochondrial membrane vesicles involves Yol027/Letm1 proteins."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The replacement of the yeast Yol027p by the human Letm1 protein restores K+/H+ exchange activity confirming functional homology of the yeast and human proteins."
      explanation: >-
        Validates the complementation assay by showing the human protein
        functionally replaces the yeast one.

animal_models:
- name: Letm1 heterozygous knockout mouse
  species: Mouse
  genotype: Letm1 +/- (heterozygous null)
  publication: PMID:23716663
  description: >-
    Homozygous Letm1 deletion is embryonic lethal before day 6.5, and about half
    of heterozygotes died before day 13.5. Surviving heterozygotes showed
    altered glucose metabolism, impaired control of brain ATP levels and
    increased seizure activity.
  modeled_mechanisms:
  - target: Perturbed Mitochondrial Calcium Handling
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    description: >-
      Supports a link from Letm1 dosage to mitochondrial Ca2+ handling and brain
      energy failure, but only in the heterozygous state.
    limitations: >-
      This is a heterozygous model of a recessive human disease - the genotype
      that matches human patients is embryonic lethal in mouse, so the model
      cannot reproduce the human bi-allelic condition at all. It was also
      designed and interpreted as a Wolf-Hirschhorn haploinsufficiency model,
      not a model of bi-allelic LETM1 disease, and it assumes the contested
      Ca2+/H+ antiporter assignment.
    evidence:
    - reference: PMID:23716663
      reference_title: "Letm1, the mitochondrial Ca2+/H+ antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The surviving heterozygous mice exhibited altered glucose metabolism, impaired control of brain ATP levels, and increased seizure activity."
      explanation: >-
        Supports treating Letm1 dosage as informative for brain energy failure
        and seizure susceptibility, with the heterozygous caveat above.

- name: Drosophila DmLETM1 tissue-specific knockdown
  species: Fruit fly
  genotype: DmLETM1 (CG4589) RNAi knockdown
  publication: PMID:20026556
  description: >-
    Conditional RNAi depletion of the Drosophila LETM1 ortholog produced
    mitochondrial swelling, developmental lethality and, with neuron-specific
    knockdown, impaired locomotor behaviour and reduced synaptic neurotransmitter
    release. DmLETM1 complements K+/H+ exchange activity in LETM1-deficient
    yeast, tying the fly phenotype to the KHE function.
  modeled_mechanisms:
  - target: Defective Mitochondrial K+/H+ Exchange
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Establishes that the LETM1 ortholog's osmoregulatory KHE activity is the
      conserved function whose loss produces the mitochondrial phenotype.
    limitations: >-
      An invertebrate RNAi knockdown rather than a point-mutation model of the
      human alleles; knockdown efficiency is graded and not equivalent to the
      bi-allelic human genotype.
    evidence:
    - reference: PMID:20026556
      reference_title: "A Drosophila mutant of LETM1, a candidate gene for seizures in Wolf-Hirschhorn syndrome."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Taken together our results demonstrate the function of DmLETM1 as a mitochondrial osmoregulator through its KHE activity"
      explanation: >-
        Supports the model as informative for the K+/H+ exchange mechanism in a
        whole organism.

- name: Zebrafish letm1 knockout
  species: Zebrafish
  genotype: letm1-/- (16-bp TALEN deletion, protein-null)
  publication: DOI:10.26508/lsa.202101194
  description: >-
    A viable germline letm1-null vertebrate - notable in itself, because
    homozygous Letm1 deletion is embryonic lethal in mouse, so this is the only
    whole-vertebrate model in which complete loss of the protein can be studied
    at all. Mutants show deregulated mitochondrial nucleotide metabolism with
    reduced NAD+ and NADH pools, scarce and damaged skeletal muscle mitochondria
    with blurred cristae, and increased amplitude of circadian clock gene
    expression. The study was designed as chronobiology of Wolf-Hirschhorn
    seizure biology, not as a model of bi-allelic LETM1 disease.
  modeled_mechanisms:
  - target: Cellular Energy Failure in High-Demand Tissues
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    description: >-
      Complete loss of Letm1 in a whole vertebrate depletes the NAD+/NADH pool
      and deregulates mitochondrial nucleotide metabolism, which is a redox and
      energy-supply lesion downstream of the same osmoregulatory defect.
    limitations: >-
      Fidelity is graded LOW for three reasons. The readout is a redox and
      circadian phenotype rather than the respiratory chain deficiency that
      defines the human disease, and no NAD measurement exists in any affected
      individual, so the link to the human node is inferential. The mutants
      segregate into compensating and non-compensating developers, so the
      phenotype is not uniform even within the model. And the null genotype is
      viable in fish but embryonic lethal in mouse, so the species differ in
      how much loss of Letm1 an organism tolerates - which cautions against
      reading the fish severity across to human bi-allelic genotypes, most of
      which retain partial function.
    evidence:
    - reference: DOI:10.26508/lsa.202101194
      reference_title: "The cation exchanger Letm1, circadian rhythms, and NAD(H) levels interconnect in diurnal zebrafish"
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We show that mitochondrial nucleotide metabolism is deregulated in letm1−/− mutant fish, the rate-limiting enzyme of NAD+ production is up-regulated, while NAD+ and NADH pools are reduced."
      explanation: >-
        Reports the metabolic consequence of complete Letm1 loss in a whole
        vertebrate, which is what makes this model informative for the energy
        failure node despite the caveats above.
    - reference: DOI:10.26508/lsa.202101194
      reference_title: "The cation exchanger Letm1, circadian rhythms, and NAD(H) levels interconnect in diurnal zebrafish"
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Here we established a viable letm1 knock-out, using the diurnal vertebrate Danio rerio to study the metabolic and chronobiological consequences of letm1 deficiency."
      explanation: >-
        Establishes that this is a viable germline null, the property that
        distinguishes it from the embryonic-lethal mouse knockout and makes a
        complete-loss vertebrate phenotype observable.

- name: Rat lentiviral Letm1 knockdown
  species: Rat
  genotype: LV-Letm1-sh lentiviral knockdown
  publication: PMID:23645710
  description: >-
    Lentiviral Letm1 knockdown in rat produced mitochondrial swelling, reduced
    the Letm1 target protein MT-CYB, and lowered the seizure threshold - earlier
    first seizure, increased frequency and duration. Notably, the synthetic
    K+/H+ exchanger nigericin failed to prevent epilepsy in this model.
  modeled_mechanisms:
  - target: Mitochondrial Matrix Swelling and Cristae Disorganization
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reproduces mitochondrial swelling in vivo on Letm1 depletion and links it
      to reduced respiratory chain subunit content.
    limitations: >-
      A somatic knockdown in a pilocarpine epilepsy paradigm designed around
      Wolf-Hirschhorn seizure biology, not a germline bi-allelic model. The
      negative nigericin result here contrasts with the positive nigericin
      rescue of membrane potential in patient fibroblasts, so the two should not
      be read as the same experiment.
    evidence:
    - reference: PMID:23645710
      reference_title: "Association of mitochondrial letm1 with epileptic seizures."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Letm1 knock-down by a lentivirus bearing LV-Letm1-sh resulted in mitochondrial swelling and decreased expression of Letm1 target protein mitochondrially encoded cytochrome B (MT-CYB)."
      explanation: >-
        Supports the model as informative for the swelling node and connects it
        to loss of a respiratory chain subunit.

discussions:
- discussion_id: letm1_transport_identity
  kind: CONTROVERSY
  status: OPEN
  prompt: >-
    Is LETM1 the mitochondrial K+/H+ exchanger, a Ca2+/H+ antiporter, both, or
    neither - and which activity is the one whose loss causes this disease?
  attaches_to:
  - pathophysiology#Defective Mitochondrial K+/H+ Exchange
  - pathophysiology#Perturbed Mitochondrial Calcium Handling
  - mechanistic_hypotheses#letm1_k_h_exchange
  - mechanistic_hypotheses#letm1_ca_h_exchange
  rationale: >-
    This is a live disagreement in the primary literature, not a gap in
    curation, and the entry deliberately represents both positions rather than
    picking a side. The K+/H+ assignment came first, from submitochondrial
    particle kinetics with loss and cross-species rescue, and is the activity
    the human disease study actually measured in proband material. The Ca2+/H+
    assignment came from a genome-wide RNAi screen with liposome reconstitution
    of purified protein, which is strong biochemistry, but a later study
    identified TMBIM5/MICS1 - a validated LETM1 interactor - as the Na+-
    independent Ca2+/H+ exchanger and concluded explicitly that LETM1 is not.

    A mechanistic objection applies to both transport claims: it is unclear how
    a single-transmembrane protein could mediate ion exchange at all, which is
    why oligomer and protein-complex models have been proposed. Alternative core
    functions - a mitochondrial translation factor, a ribosome or mtDNA
    organiser, a cristae and respiratory complex stabiliser - are also on the
    table, and a 2024 review concludes the core function remains elusive.

    Practical consequence for this entry: the pathograph spine runs through the
    K+/H+ arm, because that is what was assayed in patients' own cells and what
    the nigericin rescue supports. The Ca2+ arm is curated as a separate node
    with an ALTERNATIVE hypothesis group and no patient-level evidence. Anyone
    revising this entry should not quietly promote the Ca2+ arm without new
    human data.
  evidence:
  - reference: PMID:39481506
    reference_title: "The mysteries of LETM1 pleiotropy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Undisputedly, osmoregulatory processes are essential for mitochondrial functionality, but the pleiotropic aspects of LETM1 challenges us to understand the core function of LETM1, which still remains elusive."
    explanation: >-
      A 2024 review states directly that LETM1's core function is unresolved,
      which is the controversy this discussion records.
  - reference: PMID:22641639
    reference_title: "Perspectives on: SGP symposium on mitochondrial physiology and medicine: the pathophysiology of LETM1."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "To add further complexity, LETM1 has been recently proposed to catalyze mitochondrial H+–Ca2+ exchange, which would imply a role in mitochondrial Ca2+ homeostasis as well."
    explanation: >-
      Frames the Ca2+ proposal as an addition to, and complication of, the
      established K+/H+ role - the shape of the dispute.
  - reference: PMID:30012579
    reference_title: "LETM1 couples mitochondrial DNA metabolism and nutrient preference."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we show that LETM1 is associated with mitochondrial ribosomes, is required for mitochondrial DNA distribution and expression, and regulates the activity of an ancillary metabolic enzyme, pyruvate dehydrogenase"
    explanation: >-
      Evidence for a third candidate core function - mitochondrial translation
      and mtDNA organisation - that is neither of the two transport hypotheses,
      which is why the controversy is not simply K+ versus Ca2+.

- discussion_id: letm1_genotype_phenotype_and_natural_history
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    What determines whether a given bi-allelic LETM1 genotype produces a slowly
    progressive course compatible with survival into the fourth decade or a
    rapid course fatal in infancy?
  attaches_to:
  - progression#Progressive course
  - genetic#LETM1
  - treatments#
  rationale: >-
    The entire clinical literature is one cohort of 18 individuals from 11
    families, published in 2022, with no subsequent case series located in
    PubMed as of this curation. Within that cohort the tempo of progression
    varies from rapid infantile death to survival at 35 and 39 years, but the
    cohort is far too small to correlate that range with allele class - missense
    versus truncating, or residual K+/H+ exchange activity in the yeast assay.
    Six of the eighteen were deceased with only limited clinical records
    available, which further limits phenotyping.

    No prospective natural-history study, no biomarker of progression beyond
    lactate, and no therapeutic trial exists. The `treatments#` section is
    attached here because its emptiness of disease-modifying options is itself
    the gap: nigericin corrected membrane potential in proband fibroblasts,
    which is a mechanistic lead worth pursuing, but it failed to prevent
    epilepsy in the rat knockdown model and has never been tested clinically.
    Ketone bodies restored mitochondrial shape without restoring membrane
    potential, so that lead is also unresolved.
  evidence:
  - reference: PMID:36055214
    reference_title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Only limited clinical data were obtainable from 6 deceased persons belonging to families 3 and 10."
    explanation: >-
      Documents the incompleteness of phenotyping within the only reported
      cohort, which is the basis for this gap.

references:
- reference: PMID:36055214
  title: "Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement."
- reference: PMID:39481506
  title: "The mysteries of LETM1 pleiotropy."
- reference: DOI:10.26508/lsa.202101194
  title: "The cation exchanger Letm1, circadian rhythms, and NAD(H) levels interconnect in diurnal zebrafish"

📚

References & Deep Research

References

3

PMID:36055214

Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement.

No top-level findings curated for this source.

PMID:39481506

The mysteries of LETM1 pleiotropy.

No top-level findings curated for this source.

DOI:10.26508/lsa.202101194

The cation exchanger Letm1, circadian rhythms, and NAD(H) levels interconnect in diurnal zebrafish

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Record notes

Not Wolf-Hirschhorn syndrome. LETM1 lies in the 4p16.3 Wolf-Hirschhorn critical region (WHSCR-2), and dismech curates that contiguous-gene deletion disorder separately as `Wolf-Hirschhorn_Syndrome`. The two entries are distinct diseases and must not share phenotype, prevalence or evidence content. Wolf-Hirschhorn syndrome results from a de novo monoallelic 4p16.3 deletion removing LETM1 together with WHSC1/NSD2, CPLX1, PIGG and other genes, and human deletion mapping has shown that LETM1 haploinsufficiency alone is neither necessary nor sufficient for the WHS seizure phenotype. This entry, by contrast, is the bi-allelic (recessive) LETM1 disease first delineated in 2022: a primary mitochondrial disorder in individuals with two variant LETM1 alleles and no 4p16.3 deletion, 67% of them from consanguineous unions. The historical interest in LETM1 as a WHS seizure candidate gene is why much of the older functional literature is framed around WHS; that work is cited here for LETM1 protein function, not for WHS clinical content. The WHS-like dysmorphology is curated here, and it strengthens rather than weakens that separation. The defining cohort reports that these bi-allelic individuals show "a milder spectrum of WHS signs that has not been previously ascribed to the LETM1 deletion" - thin habitus, low-set ears, microcephaly, micrognathia and low body weight - and this entry records those features (`Facial Dysmorphism`, `Microcephaly`, `Micrognathia`, `Low-Set Ears`) rather than suppressing them to make the split look cleaner. Three things keep the two entries apart nonetheless. (1) The source itself attributes the growth deficiency, microcephaly and characteristic facies of WHS to haploinsufficiency of WHSC1, "a region located far from LETM1", and offers a putative LETM1-WHSC1 interaction or an undiscovered mechanism as the explanation for the milder overlap seen here - so it treats the shared features as convergent, not as one disease reached twice. (2) The overlap is partial and attenuated: facial dysmorphism in 4/10 and an occipitofrontal circumference below the third percentile in 2/6, a mild inconstant pattern against the specific and near-constant Greek-warrior-helmet facies of WHS. (3) The features that actually dominate this entry's pathograph - lactic acidosis, diabetes, cataract, neuropathy, proximal myopathy, cerebellar ataxia, spastic-ataxic gait, hyperkinetic movement disorders and pontine/cerebellar atrophy - are named by the same source as "not typical of WHS" and as typical instead of archetypal mitochondrial disorders. The dysmorphology is a minor shared overlay; the mitochondrial phenotype is the disease. Lump/split: the MONDO parent is the broad `MONDO:0024237` inherited neurodegenerative disorder, so there is no numbered-series parent to lump into. No `has_subtypes` are curated. The 11 reported families share one reasonably conserved pathograph - every affected individual had a respiratory chain complex deficiency and the same osmoregulatory lesion was demonstrated across proband fibroblasts, muscle and yeast complementation - but rate of progression is heterogeneous (slow, moderate and rapid courses are all reported, with onset from birth to 8 years), and that heterogeneity is recorded in `progression` rather than split into subtypes. Deliberate omissions, recorded so they are not read as oversights. (1) No `diagnosis:` section. Diagnosis here is trio/exome or genome sequencing returning bi-allelic LETM1 variants in a child with a respiratory chain deficiency; there is no LETM1-specific diagnostic assay, criteria set or testing algorithm published, and the defining cohort was assembled by genotype-first matchmaking rather than through a clinical case definition. A `diagnosis:` block would restate the generic mitochondrial-disease workup already carried by `biochemical` (lactate, urine organic acids, plasma amino acids) and by the `diagnostic: true` phenotypes (respiratory chain defect, COX-negative fibres, cerebellar atrophy). This is a gap to fill when a diagnostic pathway is actually published, not an omission for lack of material. (2) The cerebellar-ataxia phenotype stays bound to `HP:0001251` Ataxia, which carries "Cerebellar ataxia" as an exact synonym, with `clinical_course: PROGRESSIVE` alongside. `HP:0002073` Progressive cerebellar ataxia was considered and not used: it pre-composes the progressiveness into the term, whereas the cited 78% sentence establishes the ataxia and not its tempo, and the separable qualifier keeps those two claims distinct. (3) Frequency is omitted on failure to thrive, feeding difficulties, respiratory distress, loss of ambulation, ragged-red fibres, micrognathia, low-set ears, high palate, teeth abnormalities, pontine hypoplasia and ventriculomegaly, in each case because the source gives no usable denominator - the reason is recorded on each phenotype rather than inferred from the absence. The rule applied throughout is that a `frequency` band is set only where the source states the fraction itself: facial dysmorphism (4/10), microcephaly (2/6), pericardial effusion (3/11) and developmental regression (9/13) carry one; the individual components of the dysmorphic pattern and the two additional neuroimaging findings, which the source reports as narrative counts inside the six-person MRI subset, do not. (4) No differential-diagnosis content. The deep-research report for this entry covers the mitochondrial and inner-membrane differentials - OPA1, ATAD3A, TARS2, SERAC1, DNAJC19, HTRA2 and Barth syndrome/TAZ - and that material is real and usable, but it is deliberately deferred rather than dropped: writing it well means curating each of those entities' discriminating features against a single 18-person cohort, which is a follow-up of its own rather than part of a first entry. Recorded here so a later review does not re-raise it as an oversight. (5) No C. elegans entry in `animal_models`, although PMID:17606466's worm result is cited on the swelling node as `MODEL_ORGANISM` evidence. The abstract-only cache reports the mutant's phenotype in a single clause with no genotype, allele or readout detail, which is not enough to fill an `AnimalModel` record honestly. The zebrafish letm1 knockout, by contrast, is curated: it is the only viable germline vertebrate null available and its source is cited by DOI rather than PMID because the Life Science Alliance article was cached from its open-access full text.

Create: LETM1-Related_Childhood-Onset_Neurodegeneration · 2026-09-01T22:40:18Z · View source

Created the entry for bi-allelic LETM1 disease (MONDO:0859304), the recessive mitochondrial disorder distinct from Wolf-Hirschhorn syndrome. DEEP RESEARCH PROVIDER: Falcon (Edison Scientific) ran and SUCCEEDED (636s, 26 citations, 1 artifact). 'just preflight-dr' was run manually against MONDO:0859304 and PASSED, with LETM1 mentioned 72 times and no competing gene. The report is committed at research/LETM1-Related_Childhood-Onset_Neurodegeneration-deep-research-falcon.md. FALCON PMID GAP: consistent with the known pattern for this provider in this repo, the report contained ZERO PMIDs - its citations are DOIs and author-year keys, and only 8 references were extractable for validation against 26 claimed citations. The report was therefore used strictly as leads. Every PMID cited in the entry was independently located via the PubMed E-utilities API and fetched with 'just fetch-reference'; no snippet was taken from the report. Four report DOIs were resolved to PMIDs via the PMC ID converter and proved genuinely additive over my own PubMed searches: PMID:32139798 (LETM1 organizes cristae via proteoliposome reconstitution), PMID:29123128 (PINK1 phosphorylates LETM1 at Thr192 to regulate mitochondrial Ca2+ and protect neurons), and PMID:30012579 (LETM1 associates with mitochondrial ribosomes and regulates pyruvate dehydrogenase - a third candidate core function). The report's term validation flagged HP:0001244 as nonexistent in HPO; it was not bound. Its two 'mislabelled' flags (HP:0100022, HP:0000518) were markdown-parsing artifacts, and HP:0000518 Cataract was verified correct with OAK before use. CONTENT: 15 PMIDs, 58 evidence items all with snippets verified against the local cache. Pathograph is a connected 8-node chain from biallelic LETM1 loss of function through defective mitochondrial K+/H+ exchange, matrix swelling with cristae disorganization, membrane potential depolarization, respiratory chain complex deficiency, and cellular energy failure, to progressive neurodegeneration and multisystem involvement, which fans out to 10 phenotype nodes. Eleven clinical phenotypes with cohort frequencies mapped to FrequencyEnum from the reported percentages (respiratory chain deficiency 100% OBLIGATE through diabetes 27% OCCASIONAL). Biochemical: lactate, 3-methylglutaconic aciduria, alanine. Muscle histopathology as COX-negative and ragged-red fiber phenotypes. CONTESTED MECHANISM: the K+/H+ versus Ca2+/H+ transport question was represented as contested rather than resolved, per the curation brief. Two mechanistic_hypotheses groups were created - letm1_k_h_exchange (CANONICAL, evidenced by PMID:15904662 yeast loss-and-rescue) and letm1_ca_h_exchange (ALTERNATIVE, PMID:19797662 SUPPORT for the antiporter claim and PMID:36321428 REFUTE for the TMBIM5 result showing LETM1 is not the Ca2+/H+ exchanger). A CONTROVERSY discussion attaches to both nodes and both hypothesis groups and also records the third candidate core function and the 2024 review (PMID:39481506) stating the core function remains elusive. The pathograph spine deliberately runs through the K+/H+ arm because that is the activity assayed in patient-derived material; the Ca2+ node is marked HYPOTHETICAL with no patient-level evidence. A separate KNOWLEDGE_GAP discussion records the absent genotype-phenotype correlation, absent natural history, and absent disease-modifying therapy. NAMED ENTITY CONFUSION CONTROL: kb/disorders/Wolf-Hirschhorn_Syndrome.yaml was read before curation. No phenotype, prevalence, or evidence content was imported from it. The distinction (de novo monoallelic 4p16.3 contiguous-gene deletion versus bi-allelic LETM1 variants) is recorded in the entry notes. Older LETM1 functional literature framed around WHS seizure candidacy is cited only for LETM1 protein function; the three animal models carry explicit limitations stating they were built as WHS haploinsufficiency models, and the mouse model additionally notes that the genotype matching human patients is embryonic lethal in mouse. MODEL VERSUS HUMAN EVIDENCE: all yeast, fly, worm, rat and mouse evidence is graded MODEL_ORGANISM or IN_VITRO. No human phenotype is supported by model evidence alone - all eleven clinical phenotypes cite the human cohort PMID:36055214. LUMP/SPLIT: curated as its own DISEASE entry. MONDO parent is the broad MONDO:0024237, so no numbered-series parent exists. The 11 families share one reasonably conserved pathograph (universal respiratory chain deficiency; the same osmoregulatory lesion shown in fibroblasts, muscle and yeast complementation); heterogeneity is in tempo of progression, recorded in progression rather than split into has_subtypes. MODULE CONFORMANCE: one node conforms to mitochondrial_dysfunction#Bioenergetic Decline and Oxidative Stress, following the precedent set by Combined_Oxidative_Phosphorylation_Deficiency_42. The conformance note records that the module's age-related upstream node does not apply to a childhood-onset nuclear-gene defect and that the module's ROS arm was not measured in this cohort, so conformance is declared at that single node. VALIDATION: just validate-disorders PASSED (authoritative, run to completion). just validate, validate-terms, count-verified-snippets (58/58), check-duplicate-keys, check-entity-refs, check-causal-targets, check-qualifier-terms, check-enum-values, check-stubs, check-title-snippets, check-folded-hyphens, check-snippet-length, check-snippet-grading and check-environmental-evidence all pass. Three self-inflicted defects were caught by the gates and fixed: a paper title used as an evidence snippet in the classifications block, two folded-scalar hyphen splits, and a variant snippet that misquoted the family identifier (F1 rather than F1:S2). No qualifier terms were added, so check-qualifier-terms-online was not required. references_cache/PMID_36055214.md was upgraded from abstract-only to full text by fetch-reference; the change is purely additive and Wolf-Hirschhorn_Syndrome, which cites the same paper, was re-checked and still verifies 169/169. The stub was deleted.

Falcon ▸

LETM1-Related Childhood-Onset Neurodegeneration: Disease Characteristics Report

Edison Scientific Literature 26 citations 2026-09-01T16:24:36.768523

LETM1-Related Childhood-Onset Neurodegeneration: Disease Characteristics Report

Executive summary

LETM1-related childhood-onset neurodegeneration is a newly delineated, autosomal-recessive mitochondrial disorder caused by biallelic pathogenic variants in LETM1, which encodes an inner-mitochondrial-membrane protein required for cation/osmotic homeostasis, mitochondrial volume control, cristae integrity, and oxidative phosphorylation. The preferred curated name is “neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction” (MONDO:0859304). The defining 2022 cohort comprised only 18 affected individuals from 11 unrelated families; therefore, all frequencies and genotype–phenotype conclusions remain provisional. Neurological disease predominates, but optic, auditory, muscular, cardiac, endocrine, respiratory, and ocular involvement can occur. No disease-modifying therapy or LETM1-specific clinical trial is established. (OpenTargets Search: -LETM1, kaiyrzhanov2022biallelicletm1variants pages 3-4, kaiyrzhanov2022biallelicletm1variants pages 1-3)

The following table summarizes the highest-confidence evidence.

Domain	Best-supported finding	Evidence level
Disease identifier	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction; MONDO:0859304; LETM1 is the associated gene (OpenTargets Search: -LETM1)	Curated disease-gene resource
Core cohort	Defining report identified 18 affected individuals from 11 unrelated families with bi-allelic LETM1 variants (kaiyrzhanov2022biallelicletm1variants pages 5-6, kaiyrzhanov2022biallelicletm1variants pages 3-4)	Human clinical primary study
Inheritance	Autosomal recessive disease caused by biallelic LETM1 variants; 67% of families reportedly consanguineous (kaiyrzhanov2022biallelicletm1variants pages 5-6, kaiyrzhanov2022biallelicletm1variants pages 8-10)	Human genetic evidence
Onset/course	Infantile onset in 78% (14/18) and early childhood onset in 22% (4/18); progression ranged from rapid to slow, with regression common (kaiyrzhanov2022biallelicletm1variants pages 5-6, kaiyrzhanov2022biallelicletm1variants pages 16-17)	Human clinical primary study
Major phenotypes	Global developmental delay 94%, optic atrophy 83%, sensorineural hearing loss 78%, cerebellar ataxia 78%, epilepsy 67%, spasticity 53%, myopathy 50%, cataracts 42-45%, cardiomyopathy 36%, diabetes 27% (kaiyrzhanov2022biallelicletm1variants pages 1-3, kaiyrzhanov2022biallelicletm1variants pages 8-10)	Human clinical primary study
Mortality/prognosis	9/18 died, ages 2 months to 8 years; overall spectrum ranges from early lethal infantile disease to survival into adulthood with major disability (kaiyrzhanov2022biallelicletm1variants pages 5-6, kaiyrzhanov2022biallelicletm1variants pages 10-12)	Human clinical primary study
Diagnostic findings	Respiratory chain enzyme deficiencies in all tested individuals; elevated lactate 8/12; abnormal urine organic acids 9/11 including 3-methylglutaconic acid in 5/11; MRI often showed optic pathway atrophy and infratentorial abnormalities; muscle biopsy often showed COX-deficient/ragged-red fibers; EMG/NCS showed neurogenic and myopathic changes (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 8-10)	Human clinical/laboratory evidence
Molecular diagnosis	Exome sequencing with segregation/Sanger confirmation was used in the defining cohort; disease should be distinguished from contiguous 4p16.3 deletion disorders such as Wolf-Hirschhorn syndrome (kaiyrzhanov2022biallelicletm1variants pages 8-10, kaiyrzhanov2022biallelicletm1variants pages 3-4)	Human diagnostic implementation
Functional disease evidence	Patient fibroblasts/muscle and yeast assays showed disturbed mitochondrial morphology, reduced membrane potential, OXPHOS defects, and impaired K+/H+ exchange; nigericin rescue supported an osmotic/cation-homeostasis defect (kaiyrzhanov2022biallelicletm1variants pages 16-17, kaiyrzhanov2022biallelicletm1variants pages 17-18, mcquibban2010adrosophilamutant pages 2-3)	Human cells + model systems
Mechanism summary	Best-supported model is LETM1-dependent inner-membrane cation/osmotic homeostasis, especially K+/H+ exchange, required for mitochondrial volume control, cristae integrity, and OXPHOS maintenance; however, LETM1 ion-substrate assignment remains debated because Ca2+/H+ transport has also been proposed and TMBIM5 was identified as the principal mammalian mitochondrial Ca2+/H+ antiporter (nakamura2020themitochondrialinner pages 1-2, austin2022tmbim5isthe pages 1-2, lin2024anaiinformednmr pages 1-3)	Mixed human, cellular, structural, model evidence
Therapy/trials	No disease-specific therapy and no LETM1-specific interventional trial were identified; management is currently supportive and symptom-directed (kaiyrzhanov2022biallelicletm1variants pages 8-10)	Evidence of absence from available clinical sources

Table: This compact table summarizes the strongest currently available evidence for LETM1-related childhood-onset neurodegeneration, including identifiers, core cohort facts, phenotype frequencies, diagnostics, mechanism, and treatment status. It is useful as a quick-reference evidence snapshot for a disease knowledge base.

1. Disease information

Definition and scope

This disorder is an infantile- or early-childhood-onset mitochondrial encephaloneuromyopathy characterized by developmental delay followed frequently by regression, optic and auditory impairment, ataxia, epilepsy, spasticity, myopathy, and variably severe multisystem disease. The causal entity is biallelic sequence variation in LETM1, not the heterozygous 4p16.3 contiguous-gene deletion responsible for Wolf–Hirschhorn syndrome (WHS). LETM1 haploinsufficiency has long been investigated as one contributor to WHS mitochondrial and seizure phenotypes, but WHS is genetically and clinically distinct. (kaiyrzhanov2022biallelicletm1variants pages 3-4, kaiyrzhanov2022biallelicletm1variants pages 1-3, durigon2018letm1couplesmitochondrial pages 1-2)

Identifiers and synonyms

MONDO: MONDO:0859304, neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction.
Gene: LETM1, approved name leucine zipper and EF-hand containing transmembrane protein 1; Ensembl ENSG00000168924. (OpenTargets Search: -LETM1)
Useful synonyms: biallelic LETM1-related disorder; LETM1-related mitochondrial disease; LETM1-related neurodegeneration; bi-allelic LETM1-associated mitochondrial ion-homeostasis disorder.
OMIM/Orphanet/MeSH/ICD-10/ICD-11: no disease-specific identifier was established in the retrieved evidence. Coding should therefore use the appropriate broader mitochondrial disease/neurodegeneration code locally rather than treating WHS as synonymous.
Evidence granularity: current knowledge is aggregated mainly from one international disease-level case series, although its source observations were individual clinical records, family segregation data, imaging, biochemical investigations, biopsies, and patient-derived cells. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 5-6)

Defining publication: Kaiyrzhanov et al., American Journal of Human Genetics, published September 1, 2022; PMID 36055214; DOI 10.1016/j.ajhg.2022.07.007. Its title precisely states the central conclusion: “Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement.” (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 3-4)

2. Etiology, risk, and protective factors

Causal factor

The primary cause is germline biallelic LETM1 variation, including missense, in-frame deletion, and frameshift/loss-of-function alleles. Functional evidence supports partial or severe loss of LETM1 activity rather than an environmental etiology. Patient fibroblasts and muscle, together with yeast complementation assays, showed impaired K+/H+ exchange, abnormal mitochondrial morphology, reduced membrane potential, loss of respiratory-chain components, and defective oxidative phosphorylation. (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 16-17, kaiyrzhanov2022biallelicletm1variants pages 1-3)

Reported alleles included c.878T>A (p.Ile293Asn), c.754_756del (p.Lys252del), c.881G>A (p.Arg294Gln), c.898C>T (p.Pro300Ser), c.1072G>A (p.Asp358Asn), c.1139G>C (p.Arg380Pro), c.2094del (p.Asp699Metfs13), and a C-terminal frameshift reported as p.Val691fs4. One reported compound-heterozygous genotype was c.[878T>A;2094del], p.[Ile293Asn;Asp699Metfs13]. Variant representation should be revalidated against the clinical transcript NM_012318.3*, because spacing and terminal notation vary in the source extraction. (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 16-17)

Risk factors

Genetic: having pathogenic/likely pathogenic variants on both LETM1 alleles is the established risk factor. Parental consanguinity was reported for approximately 67% of the defining cohort, increasing the probability of homozygosity but not itself causing disease. (kaiyrzhanov2022biallelicletm1variants pages 5-6)
Family history: affected siblings and carrier parents support autosomal-recessive inheritance. A negative family history does not exclude the disorder.
Environmental, infectious, occupational, lifestyle, age, and sex risks: none are established. The cohort included 10 males and 8 females, providing no evidence of sex linkage or meaningful sex bias. (kaiyrzhanov2022biallelicletm1variants pages 5-6)

Protective factors and gene–environment interaction

No validated protective human allele, modifier gene, diet, lifestyle factor, or exposure has been identified. Ketone-body conditions altered survival and mitochondrial phenotypes in WHS-derived fibroblasts, and the investigators proposed that altered nutrient use might mitigate LETM1-related mitochondrial dysfunction; however, this is cellular evidence from WHS haploinsufficiency, not proof that a ketogenic diet benefits biallelic LETM1 disease. It should not be implemented without specialist metabolic and epilepsy supervision. (durigon2018letm1couplesmitochondrial pages 1-2)

Likewise, zebrafish work proposed NAD-pool replenishment after finding reduced NAD+ and NADH, but no affected human has demonstrated clinical benefit. These are hypothesis-generating gene–nutrient interactions, not established protective interventions. (dao2022thecationexchanger pages 1-2, dao2022thecationexchanger pages 2-4)

3. Phenotypes

Frequencies below use the small 2022 cohort and denominators varied by test availability; absence of a feature was not always systematically assessed. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 1-3)

Core neurological and developmental phenotypes

Global developmental delay — 94%: usually infantile, severe and often progressive; suggested HPO: Global developmental delay (HP:0001263). Daily effects include dependence in mobility, communication, self-care, education, and feeding. (kaiyrzhanov2022biallelicletm1variants pages 1-3)
Developmental/cognitive-motor regression — 9/13, 69%: loss of acquired skills and, in ambulant patients, loss of walking at a mean age of approximately 5.4 years; suggested HPO: Developmental regression (HP:0002376) and Loss of previously acquired motor skills (HP:0001244). (kaiyrzhanov2022biallelicletm1variants pages 5-6)
Cerebellar ataxia — 78%: progressive or variably progressive gait/limb incoordination; HPO: Cerebellar ataxia (HP:0001251), Abnormality of gait (HP:0001288). (kaiyrzhanov2022biallelicletm1variants pages 1-3)
Epilepsy — 67%: median reported onset about five years, with infantile spasms, myoclonic jerks, absences, and generalized tonic–clonic seizures; some patients developed pharmacoresistance or epileptic encephalopathy. HPO: Seizure (HP:0001250), with subtype terms applied individually. Seizures can substantially impair cognition, safety, sleep, and family quality of life. (kaiyrzhanov2022biallelicletm1variants pages 8-10)
Spasticity — 53%: may combine with ataxia and cause progressive gait loss; HPO: Spasticity (HP:0001257). (kaiyrzhanov2022biallelicletm1variants pages 1-3)
Central hypotonia: common presenting sign but no reliable cohort percentage was retrieved; HPO: Muscular hypotonia (HP:0001252). (kaiyrzhanov2022biallelicletm1variants pages 5-6)
Hyperkinetic movements — approximately 33%: HPO: Hyperkinetic movements (HP:0100022). (kaiyrzhanov2022biallelicletm1variants pages 8-10)

Neurosensory, muscular, and imaging phenotypes

Optic atrophy — 83%; MRI showed optic-nerve/chiasm atrophy in 4/6 imaged individuals. HPO: Optic atrophy (HP:0000648). It can produce severe visual disability. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 1-3)
Sensorineural hearing loss — 78%: HPO: Sensorineural hearing impairment (HP:0000407); it compounds speech, education, and communication impairment. (kaiyrzhanov2022biallelicletm1variants pages 1-3)
Myopathy — 50%: weakness, reduced endurance, and respiratory vulnerability; HPO: Myopathy (HP:0003198) and Muscle weakness (HP:0001324). EMG showed neurogenic changes in 3/5 and myopathic changes in 2/4 tested individuals. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 1-3)
Cerebellar atrophy, pontine hypoplasia, ventricular dilatation: suggested HPO terms Cerebellar atrophy (HP:0001272), Pontine hypoplasia (HP:0012110), and Ventriculomegaly (HP:0002119). Abnormalities were generally infratentorial/bilateral rather than lateralized focal lesions. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 8-10)

Multisystem phenotypes

Bilateral cataracts — approximately 42–45%: HPO: Cataract (HP:0000518) and Bilateral cataracts; potentially treatable visual morbidity. (kaiyrzhanov2022biallelicletm1variants pages 1-3, kaiyrzhanov2022biallelicletm1variants pages 8-10)
Cardiomyopathy — 36%: sometimes associated with pericardial effusion; HPO: Cardiomyopathy (HP:0001638) and Pericardial effusion (HP:0001698). (kaiyrzhanov2022biallelicletm1variants pages 8-10)
Diabetes mellitus — 27%: HPO: Diabetes mellitus (HP:0000819). (kaiyrzhanov2022biallelicletm1variants pages 1-3)
Respiratory distress/insufficiency and feeding difficulty: important in rapidly progressive cases; HPO: Respiratory insufficiency (HP:0002093) and Feeding difficulties (HP:0011968). (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 5-6)
Failure to thrive/low weight/thin habitus: HPO: Failure to thrive (HP:0001508) and Underweight (HP:0004325). (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 5-6)
Microcephaly, micrognathia, low-set ears, and variable facial dysmorphism: HPO: Microcephaly (HP:0000252), Micrognathia (HP:0000347), and Low-set ears (HP:0000369). These are variable and not sufficient for clinical diagnosis. (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 8-10)

Laboratory abnormalities

Elevated serum lactate occurred in 8/12 (67%); plasma amino acids were abnormal in 4/9; urine organic acids were abnormal in 9/11, including 3-methylglutaconic aciduria in 5/11. Respiratory-chain enzyme analysis was abnormal in every tested affected person (11 individuals). Muscle biopsy was abnormal in 5/7, including COX-deficient fibers, ragged-red fibers, and abnormal mitochondria. Suggested HPO: Lactic acidemia (HP:0003128), 3-methylglutaconic aciduria (HP:0003535), Ragged-red muscle fibers (HP:0003200), and Cytochrome-c oxidase deficiency (HP:0003201). (kaiyrzhanov2022biallelicletm1variants pages 16-17, kaiyrzhanov2022biallelicletm1variants pages 10-12)

No disease-specific EQ-5D, SF-36, PROMIS, or caregiver-burden study exists. Quality-of-life effects must therefore be inferred from severe neurodevelopmental disability, sensory loss, seizures, loss of ambulation, feeding/respiratory support needs, and early mortality.

4. Genetic and molecular information

Gene and protein

LETM1 encodes a highly conserved inner-mitochondrial-membrane protein containing a transmembrane region, LETM domain, and C-terminal EF-hand-related calcium-sensing region. It participates in mitochondrial cation/osmotic balance, volume regulation, cristae organization, respiratory competence, and mitochondrial nucleoprotein/ribosome biology. Disease alleles are germline and inherited recessively; there is no evidence that somatic LETM1 mutation causes this pediatric disorder. (kaiyrzhanov2022biallelicletm1variants pages 3-4, nakamura2020themitochondrialinner pages 1-2, durigon2018letm1couplesmitochondrial pages 1-2)

Variant interpretation

Variant interpretation should follow ACMG/AMP criteria and integrate rarity, segregation, phenotype specificity, predicted consequence, conserved-domain location, and functional evidence. The defining study identified rare protein-altering alleles by exome sequencing and confirmed variants and segregation by Sanger sequencing. Because the cohort is small, individual ClinVar classifications and current gnomAD frequencies should be checked at the time of diagnosis rather than inferred from publication inclusion. (kaiyrzhanov2022biallelicletm1variants pages 8-10)

The available functional results support a predominantly loss-of-function/hypomorphic model: frameshifts reduce functional protein, whereas missense and in-frame deletion alleles impair ion exchange, morphology, membrane potential, and/or OXPHOS to variable degrees. A dominant-negative mechanism has not been demonstrated. (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 16-17)

Modifiers, epigenetics, and chromosomal abnormalities

No validated modifier gene, DNA-methylation signature, histone/chromatin defect, anticipation mechanism, or disease-specific epigenomic profile is known. PINK1 phosphorylates LETM1 at Thr192 in experimental neurons and regulates calcium handling, making it a mechanistic regulator rather than a proven human clinical modifier. (huang2017pink1mediatedphosphorylationof pages 1-2)

Large heterozygous deletions encompassing LETM1 occur in 4p16.3/Wolf–Hirschhorn syndrome, but they are not equivalent to biallelic LETM1-related neurodegeneration. Chromosomal microarray is appropriate when WHS or another copy-number disorder is suspected; sequence-based testing is needed for the recessive disorder. (kaiyrzhanov2022biallelicletm1variants pages 3-4, durigon2018letm1couplesmitochondrial pages 1-2)

5. Environmental information

No toxin, radiation, pollutant, occupational exposure, smoking, alcohol, diet, exercise pattern, bacterium, virus, fungus, or parasite is known to cause or trigger the disorder. It is not infectious or transmissible. Intercurrent illness, fasting, anesthesia, and metabolic stress may plausibly worsen mitochondrial disease, but LETM1-specific human evidence was not retrieved. Standard mitochondrial-disease precautions are therefore based on general practice, not disease-specific trials.

6. Mechanism and pathophysiology

Ordered causal chain

Biallelic damaging LETM1 variants lead to reduced or dysfunctional LETM1 protein in the inner mitochondrial membrane. (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 16-17)
LETM1 dysfunction leads to defective mitochondrial cation and osmotic regulation—best supported in the disease study as impaired K+/H+ exchange—while effects on calcium handling may be direct, indirect, or mediated through LETM1-containing complexes. (kaiyrzhanov2022biallelicletm1variants pages 16-17, austin2022tmbim5isthe pages 1-2, lin2024anaiinformednmr pages 1-3)
Abnormal ion balance leads to matrix swelling, altered membrane potential, network fragmentation, and disorganized or lost cristae. Direct membrane-shaping activity of LETM1 has also been demonstrated in reconstituted liposomes, providing a parallel structural branch. (kaiyrzhanov2022biallelicletm1variants pages 10-12, nakamura2020themitochondrialinner pages 1-2)
Cristae/inner-membrane disruption leads to destabilization or reduction of respiratory-chain/OXPHOS components and deficient respiratory-chain enzyme activity. (kaiyrzhanov2022biallelicletm1variants pages 17-18, kaiyrzhanov2022biallelicletm1variants pages 10-12)
In parallel, LETM1 dysfunction leads to altered mitochondrial ribosome assembly, mtDNA distribution/expression, mitochondrial translation, pyruvate dehydrogenase activity, and substrate preference; some links derive from WHS cells and experimental knockdown and remain inferred for biallelic disease. (durigon2018letm1couplesmitochondrial pages 1-2)
OXPHOS failure and disturbed calcium/cation signaling result in inadequate ATP production, abnormal redox and metabolic homeostasis, and increased vulnerability of high-energy cells. The precise contribution of ROS, permeability transition, mitophagy, and apoptosis in affected humans remains incompletely demonstrated.
High-energy-cell dysfunction and loss lead to neurodevelopmental impairment and progressive injury of neurons, optic pathways, auditory structures, cerebellum, muscle, myocardium, lens, and pancreatic endocrine function. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 1-3)
Tissue dysfunction results in regression, epilepsy, ataxia, spasticity, optic atrophy, hearing loss, myopathy, cardiomyopathy, diabetes, respiratory failure, and, in severe genotypes, early death. (kaiyrzhanov2022biallelicletm1variants pages 5-6, kaiyrzhanov2022biallelicletm1variants pages 1-3)

Current mechanistic interpretation and controversy

The strongest disease-linked model is failure of mitochondrial K+/H+ exchange and volume homeostasis. Patient material showed OXPHOS abnormalities, while yeast assays demonstrated impaired K+/H+ exchange and rescue with the K+/H+ ionophore nigericin. This ties genotype to a tractable biochemical defect. (kaiyrzhanov2022biallelicletm1variants pages 16-17, mcquibban2010adrosophilamutant pages 2-3)

However, LETM1 has also been described as a Ca2+/H+ exchanger or calcium regulator. A major refinement came from Austin et al. (EMBO Reports, November 2022), who found that TMBIM5, physically interacting with LETM1, rather than LETM1 itself, is the principal mammalian mitochondrial Ca2+/H+ antiporter. Their cell-free and cell-based assays showed absent or reduced Na+-independent calcium release after TMBIM5 loss or pH-sensor mutation. Thus, LETM1 may regulate calcium through a larger complex, membrane potential, osmotic state, or its own context-dependent activity rather than acting as the sole exchanger. DOI: 10.15252/embr.202254978. (austin2022tmbim5isthe pages 1-2)

A 2024 structural advance used AlphaFold2-guided NMR to identify an unusual LETM1 F-EF-hand with noncanonical Ca2+ coordination and His662-dependent pH sensing. Mutations increasing Ca2+ binding raised matrix Ca2+, whereas weakening binding lowered it, supporting a bidirectional regulatory role. The retrieved version was the April 2024 bioRxiv preprint, DOI 10.1101/2024.04.23.590744; it was subsequently associated in the search record with a 2024 Structure publication. This structural work informs LETM1 biology but did not test the pediatric disease variants directly. (lin2024anaiinformednmr pages 1-3)

Cellular processes, pathways, and ontology suggestions

Relevant GO biological-process suggestions include mitochondrial ion transmembrane transport, potassium ion transmembrane transport, calcium ion transmembrane transport, mitochondrial organization, cristae formation, oxidative phosphorylation, mitochondrial translation, mitochondrial genome maintenance, cellular respiration, and regulation of mitochondrial membrane potential. Relevant GO cellular components are mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial matrix (GO:0005759), mitochondrial crista (GO:0030061), and mitochondrial ribosome (GO:0005761).

Candidate Cell Ontology targets include neuron (CL:0000540), cerebellar neuron, retinal ganglion cell (CL:0000740), skeletal muscle cell/myocyte, cardiomyocyte (CL:0000746), pancreatic beta cell (CL:0000169), and lens epithelial cell. Direct cell-type-specific human pathology is limited, so most cellular assignments are inferred from organ phenotypes.

Molecular profiling and advanced technologies

Disease-specific single-cell RNA-seq, spatial transcriptomics, patient proteomics, metabolomics, lipidomics, multi-omics integration, organoids, or CRISPR screens have not been reported in the retrieved evidence. Bulk biochemical profiling showed respiratory-chain deficiencies, increased mtDNA copy number in affected tissue, altered OXPHOS-subunit abundance, and organic-acid/lactate abnormalities. Zebrafish knockout work showed reduced NAD+/NADH pools and altered circadian-clock expression, but this has not been validated as a human biomarker. (kaiyrzhanov2022biallelicletm1variants pages 16-17, dao2022thecationexchanger pages 1-2)

7. Anatomical structures affected

Organ and system level

The nervous system is primary: brain, cerebellum, pons, corticospinal/motor systems, optic nerves/chiasm, and peripheral neuromuscular structures. Secondary or variable involvement includes skeletal muscle, heart/pericardium, auditory system, eye lens, endocrine pancreas, respiratory system, and craniofacial/growth structures. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 1-3, kaiyrzhanov2022biallelicletm1variants pages 8-10)

Suggested UBERON mappings include brain (UBERON:0000955), cerebellum (UBERON:0002037), pons (UBERON:0000988), optic nerve (UBERON:0000966), skeletal muscle organ (UBERON:0014892), heart (UBERON:0000948), pancreas (UBERON:0001264), and lens of eye (UBERON:0000965). Auditory structures should be mapped at the most specific level documented clinically; the cohort established sensorineural loss but not a single histologically proven lesion.

Subcellular level

The initiating compartment is the inner mitochondrial membrane, with downstream matrix swelling, cristae loss, network fragmentation, respiratory-chain impairment, and altered mitochondrial nucleoprotein/ribosome organization. LETM1 localized predominantly to crista membranes in immunoelectron microscopy, and purified LETM1 directly produced invaginated membrane structures in proteoliposomes. (nakamura2020themitochondrialinner pages 1-2)

No consistent unilateral or asymmetric phenotype is established; cataracts and optic atrophy were commonly bilateral.

8. Temporal development

Onset was infantile in 14/18 (78%) and early childhood in 4/18 (22%). Presentation could include developmental delay, hypotonia, poor growth, respiratory distress, or feeding difficulty, followed by progressive neurosensory, motor, seizure, and multisystem manifestations. (kaiyrzhanov2022biallelicletm1variants pages 5-6)

The course was rapid in approximately 50%, moderately fast in 22%, and slow in 28%. Nine individuals died between two months and eight years, whereas four survived into adulthood with disability; therefore, the disease spans a severe early-lethal form and a chronic slowly progressive form. No validated staging system exists. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 5-6)

No spontaneous remission pattern is established. The early developmental period is probably the key vulnerability window because irreversible sensory and neurological injury begins in infancy or childhood, but no trial has defined a therapeutic window.

9. Inheritance and population

Inheritance is autosomal recessive. For two heterozygous carrier parents, each pregnancy has a 25% probability of an affected child, 50% probability of a carrier child, and 25% probability of a child inheriting neither familial allele, assuming standard Mendelian segregation. Penetrance among individuals with two truly pathogenic alleles appears high, but the sample is too small to quantify penetrance or age dependence.

Expressivity is markedly variable, ranging from death in infancy to adult survival with disability. No anticipation, germline mosaicism, founder effect, or validated population-specific allele has been demonstrated. Consanguinity was present in about 67% of the reported families. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 5-6)

The cohort comprised 10 males and 8 females from Pakistani, Caucasus-region, Middle Eastern, European, and Mexican backgrounds. This broad distribution argues against restriction to one ancestry, but ascertainment was referral-based rather than epidemiological. (kaiyrzhanov2022biallelicletm1variants pages 5-6)

Prevalence, incidence, carrier frequency, geographic rates, and birth prevalence are unknown. Only 18 affected individuals in the defining report must not be converted into a population prevalence estimate.

10. Diagnostics

When to suspect

Consider LETM1 disease in an infant or child with developmental delay/regression plus two or more of optic atrophy, sensorineural hearing loss, cerebellar ataxia/atrophy, epilepsy, spasticity, myopathy, cataracts, cardiomyopathy, diabetes, elevated lactate, or 3-methylglutaconic aciduria. The phenotype is not sufficiently specific for clinical diagnosis alone. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 1-3)

Recommended evaluation

Genomic testing: trio whole-exome or whole-genome sequencing is preferred, with copy-number calling and parental segregation. A comprehensive nuclear mitochondrial-disease or neurodegeneration panel that includes LETM1 is reasonable where exome/genome is unavailable. Confirm candidate variants by an orthogonal method when required. The defining cohort used exome sequencing, rare protein-altering variant filtering, Sanger confirmation, and segregation analysis. (kaiyrzhanov2022biallelicletm1variants pages 8-10)
Deletion analysis: chromosomal microarray if dysmorphism or WHS is suspected, because heterozygous 4p deletion and biallelic LETM1 sequence disease are different diagnoses.
Metabolic studies: lactate/pyruvate, blood gas, glucose/HbA1c, plasma amino acids, urine organic acids including 3-methylglutaconic acid, CK, liver/renal profile, and nutritional indices. Normal results do not exclude disease. (kaiyrzhanov2022biallelicletm1variants pages 10-12)
Neurological studies: brain/orbit MRI, EEG, developmental assessment, ophthalmology, audiology, EMG/nerve conduction where clinically indicated. EEG may show slowing, sharp transients, or spike-and-wave activity. (kaiyrzhanov2022biallelicletm1variants pages 8-10)
System surveillance: ECG and echocardiography, respiratory/sleep assessment, feeding/swallow evaluation, endocrine screening, and cataract examination.
Tissue/functional testing: muscle biopsy and respiratory-chain enzyme analysis can support mitochondrial dysfunction but are invasive and not mandatory after a convincing molecular diagnosis. In the reported cohort, all 11 respiratory-chain analyses were abnormal. (kaiyrzhanov2022biallelicletm1variants pages 10-12)

WGS may identify coding, splice, structural, and copy-number variants missed by exome/panel testing. RNA sequencing could resolve suspected splice variants, but disease-specific clinical validation is absent. mtDNA sequencing alone, repeat-expansion testing, karyotyping, or FISH will not generally diagnose biallelic LETM1 sequence disease unless another differential is suspected.

Differential diagnosis

Important alternatives include WHS/4p deletion; other nuclear mitochondrial encephalomyopathies; Barth/TAZ and other 3-methylglutaconic acidurias; OPA1, ATAD3A, TARS2, SERAC1, DNAJC19, and HTRA2-related disorders; congenital disorders featuring cataract and neuropathy; epileptic encephalopathies; and hereditary spastic-ataxia/optic-atrophy syndromes. Distinguishing evidence is the finding of two segregating disease-causing LETM1 variants plus compatible mitochondrial functional abnormalities.

No standardized clinical diagnostic criteria, newborn screen, validated circulating biomarker, or population screening program exists.

11. Outcome and prognosis

In the defining cohort, 9/18 (50%) died between two months and eight years, while four survived into adulthood with persistent disability. Ten were described as rapidly progressive and nine early deaths were recorded, emphasizing both severity and uncertainty from small denominators. (kaiyrzhanov2022biallelicletm1variants pages 10-12, kaiyrzhanov2022biallelicletm1variants pages 5-6)

No 5- or 10-year survival curve, median life expectancy, standardized disability score, or health-related quality-of-life dataset exists. Major morbidity includes profound developmental disability, regression, sensory impairment, loss of ambulation, refractory epilepsy, feeding and respiratory compromise, myopathy, cardiomyopathy, and diabetes. (kaiyrzhanov2022biallelicletm1variants pages 5-6, kaiyrzhanov2022biallelicletm1variants pages 1-3)

Possible adverse prognostic indicators are very early onset, respiratory distress, epileptic encephalopathy, severe multisystem involvement, and frameshift/severe loss-of-function genotypes, but none has been validated in a prognostic model. Variant p.Val691fs*4 was associated with rapid progression and death before one year in one family, which is insufficient to establish a general genotype–prognosis rule. (kaiyrzhanov2022biallelicletm1variants pages 17-18)

Recovery of established neurodegeneration is not documented. Early recognition may nevertheless prevent avoidable complications through seizure, cardiac, respiratory, feeding, sensory, and endocrine care.

12. Treatment and current applications

Current clinical management

There is no approved disease-modifying or genotype-specific treatment. Management should be coordinated by mitochondrial medicine, neurology, clinical genetics, cardiology, ophthalmology, audiology, endocrinology, pulmonology, nutrition, and rehabilitation.

Antiseizure medication individualized to seizure type and mitochondrial safety; ketogenic therapy cannot be recommended specifically from LETM1 fibroblast data.
Physical, occupational, speech/communication, and feeding therapies; mobility, orthotic, and augmentative communication devices.
Nutritional support and gastrostomy when swallowing or growth is unsafe/inadequate.
Respiratory support, airway-clearance therapy, sleep-disordered-breathing evaluation, and prompt infection treatment.
Standard cardiomyopathy/pericardial-effusion management.
Cataract surgery when appropriate, low-vision services, hearing aids or cochlear-implant assessment.
Standard diabetes treatment with attention to catabolic stress.
Spasticity and movement-disorder management, including physiotherapy and medications when benefits outweigh sedation/weakness.

Suggested NCIT intervention labels include Anticonvulsant Therapy, Physical Therapy, Occupational Therapy, Speech Therapy, Nutritional Support, Gastrostomy, Noninvasive Ventilation, Cataract Surgery, Hearing Aid, Cochlear Implant, and Genetic Counseling; exact NCIT codes should be validated in the current thesaurus release.

Experimental approaches

Nigericin restored mitochondrial morphology/K+/H+ exchange-related defects in fly/cellular models, but it is an ionophore and not a clinically acceptable treatment. PINK1-dependent LETM1-T192E rescued calcium mishandling and neuronal vulnerability experimentally, but no human therapy follows from this result. NAD replenishment and altered nutrient/ketone use remain preclinical hypotheses. (huang2017pink1mediatedphosphorylationof pages 1-2, durigon2018letm1couplesmitochondrial pages 1-2, mcquibban2010adrosophilamutant pages 2-3)

No LETM1-specific gene replacement, gene editing, ASO, siRNA, mRNA, cell therapy, immunotherapy, targeted drug, or clinical-trial intervention was identified. No NCT identifier or treatment-response rate is available. Consequently, adverse-event and pharmacogenomic evidence is also absent.

13. Prevention

The molecular defect cannot currently be prevented by vaccination, lifestyle change, prophylactic medication, or environmental remediation.

Primary reproductive prevention includes genetic counseling, carrier testing of at-risk relatives, partner testing where appropriate, preimplantation genetic testing for monogenic disease, prenatal diagnosis by chorionic-villus sampling or amniocentesis, and use of donor gametes. Testing must target the confirmed familial variants.

Secondary prevention consists of cascade testing and early evaluation of presymptomatic or minimally symptomatic siblings. There is no population newborn screen; targeted neonatal molecular testing is appropriate in a known family.

Tertiary prevention includes surveillance and early treatment of seizures, aspiration, malnutrition, respiratory insufficiency, cardiomyopathy, cataracts, hearing loss, diabetes, contractures, and reduced mobility. No immunization is disease-specific, although routine vaccination may reduce infectious metabolic stress.

14. Other species and natural disease

No naturally occurring veterinary LETM1 syndrome, affected breed, wildlife reservoir, zoonotic transmission, or cross-species infectious susceptibility was identified. This is a germline human genetic disorder and has no zoonotic potential.

LETM1 function is deeply conserved across eukaryotes. Ortholog studies in Saccharomyces cerevisiae, Drosophila melanogaster, Danio rerio, mice, worms, trypanosomes, fungi, and protozoa support conserved mitochondrial cation/osmotic regulation. Human LETM1 can complement aspects of divergent ortholog deficiency, strengthening functional conservation. (kaiyrzhanov2022biallelicletm1variants pages 3-4, mcquibban2010adrosophilamutant pages 1-2)

Suggested taxa include human NCBI Taxon 9606, mouse 10090, zebrafish 7955, fruit fly 7227, and budding yeast 4932. Ortholog-specific NCBI Gene identifiers should be obtained directly from current NCBI records before database loading.

15. Model organisms and experimental systems

Mouse

Letm1 haploinsufficiency alters brain glucose metabolism, pyruvate dehydrogenase activity, mitochondrial calcium handling, and ATP-related metabolism; complete loss is embryonically lethal. These models establish dosage sensitivity but model heterozygous WHS biology better than biallelic surviving human alleles. (kaiyrzhanov2022biallelicletm1variants pages 3-4, dao2022thecationexchanger pages 2-4)

Drosophila

Global DmLETM1 depletion causes third-instar developmental lethality, mitochondrial swelling, fragmented networks, and tissue-growth defects. Neuronal knockdown impairs locomotion and synaptic neurotransmitter release. Nigericin rescues mitochondrial morphology, supporting K+/H+ osmoregulation. The model recapitulates mitochondrial and neuromuscular vulnerability but not the full human multisystem natural history. DOI 10.1093/hmg/ddp563, March 2010. (mcquibban2010adrosophilamutant pages 1-2, mcquibban2010adrosophilamutant pages 2-3)

Zebrafish

A viable letm1−/− model generated by a 16-bp TALEN deletion lacks Letm1 protein. Mutants show abnormal/scarce muscle mitochondria, reduced NAD+ and NADH pools, altered mitochondrial nucleotide metabolism, and increased circadian-clock gene-expression amplitude. The authors wrote that “Replenishing NAD pool may ameliorate WHS-associated sleep and neurological disorders,” but this is a proposed experiment, not demonstrated therapy. DOI 10.26508/lsa.202101194, published online June 13, 2022. (dao2022thecationexchanger pages 1-2, dao2022thecationexchanger pages 2-4)

Yeast and other lower eukaryotes

Yeast Mdm38/LETM1-null systems are particularly useful for K+/H+ exchange, growth complementation, membrane potential, and variant functional classification. Silencing orthologs across yeast, worms, flies, trypanosomes, fungi, and protozoa commonly causes swelling, cristae loss, impaired mitochondrial translation, developmental failure, or lethality. Their strength is mechanistic conservation; their limitation is lack of human nervous-system complexity. (kaiyrzhanov2022biallelicletm1variants pages 16-17, kaiyrzhanov2022biallelicletm1variants pages 3-4)

Patient cells and reconstituted systems

Patient fibroblasts and muscle provide the most disease-proximal functional evidence: disturbed morphology, reduced membrane potential, deficient complexes I/IV or broader respiratory-chain activity, and altered mtDNA/OXPHOS measures. Purified LETM1 in proteoliposomes directly remodeled membranes into invaginations, while NMR/AlphaFold-assisted studies defined its unusual F-EF-hand. These platforms are suitable for variant testing and drug screening but cannot establish clinical efficacy. (kaiyrzhanov2022biallelicletm1variants pages 17-18, nakamura2020themitochondrialinner pages 1-2, lin2024anaiinformednmr pages 1-3)

Recent developments and expert assessment

The principal recent advance remains disease delineation in 2022; no additional large human cohort from 2023–2024 was identified. Research in 2023–2024 instead refined mechanism. Contemporary mitochondrial-calcium reviews emphasize that calcium regulates ATP production, substrate choice, ROS responses, neuronal excitability, and cell death, but they also stress transporter- and tissue-specific effects. For LETM1 disease, these general principles should not be presented as directly demonstrated patient pathology. (austin2022tmbim5isthe pages 1-2, lin2024anaiinformednmr pages 1-3)

The 2024 F-EF-hand structure supports LETM1 as a pH-sensitive calcium regulator, whereas the 2022 TMBIM5 work argues that TMBIM5—not LETM1—is the canonical mammalian Ca2+/H+ exchanger. The most defensible expert synthesis is therefore that LETM1 is an essential inner-membrane cation/osmotic and structural regulator, with strong K+/H+-homeostasis evidence and context-dependent effects on calcium, rather than a settled single-substrate ion transporter. (nakamura2020themitochondrialinner pages 1-2, austin2022tmbim5isthe pages 1-2, lin2024anaiinformednmr pages 1-3)

Evidence limitations

Human evidence is dominated by one retrospective international cohort of 18 individuals.
Phenotype denominators differ because testing was incomplete.
Variant-specific ClinVar status and population frequencies require live database verification.
Many mechanistic observations derive from WHS cells, knockdown/knockout organisms, or overexpression rather than patient alleles.
No prospective natural-history study, registry, biomarker-validation study, therapeutic trial, survival model, or formal quality-of-life study exists.
Abstract quotations are included only where wording was available from retrieved records; mechanistic statements otherwise paraphrase the primary evidence to avoid fabricating quotations.

References

(OpenTargets Search: -LETM1): Open Targets Query (-LETM1, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(kaiyrzhanov2022biallelicletm1variants pages 3-4): Rauan Kaiyrzhanov, Sami E.M. Mohammed, Reza Maroofian, Ralf A. Husain, Alessia Catania, Alessandra Torraco, Ahmad Alahmad, Marina Dutra-Clarke, Sabine Grønborg, Annapurna Sudarsanam, Julie Vogt, Filippo Arrigoni, Julia Baptista, Shahzad Haider, René G. Feichtinger, Paolo Bernardi, Alessandra Zulian, Mirjana Gusic, Stephanie Efthymiou, Renkui Bai, Farah Bibi, Alejandro Horga, Julian A. Martinez-Agosto, Amanda Lam, Andreea Manole, Diego-Perez Rodriguez, Romina Durigon, Angela Pyle, Buthaina Albash, Carlo Dionisi-Vici, David Murphy, Diego Martinelli, Enrico Bugiardini, Katrina Allis, Costanza Lamperti, Siegfried Reipert, Lotte Risom, Lucia Laugwitz, Michela Di Nottia, Robert McFarland, Laura Vilarinho, Michael Hanna, Holger Prokisch, Johannes A. Mayr, Enrico Silvio Bertini, Daniele Ghezzi, Elsebet Østergaard, Saskia B. Wortmann, Rosalba Carrozzo, Tobias B. Haack, Robert W. Taylor, Antonella Spinazzola, Karin Nowikovsky, and Henry Houlden. Bi-allelic letm1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. American Journal of Human Genetics, 109:1692-1712, Sep 2022. URL: https://doi.org/10.1016/j.ajhg.2022.07.007, doi:10.1016/j.ajhg.2022.07.007. This article has 21 citations and is from a highest quality peer-reviewed journal.
(kaiyrzhanov2022biallelicletm1variants pages 1-3): Rauan Kaiyrzhanov, Sami E.M. Mohammed, Reza Maroofian, Ralf A. Husain, Alessia Catania, Alessandra Torraco, Ahmad Alahmad, Marina Dutra-Clarke, Sabine Grønborg, Annapurna Sudarsanam, Julie Vogt, Filippo Arrigoni, Julia Baptista, Shahzad Haider, René G. Feichtinger, Paolo Bernardi, Alessandra Zulian, Mirjana Gusic, Stephanie Efthymiou, Renkui Bai, Farah Bibi, Alejandro Horga, Julian A. Martinez-Agosto, Amanda Lam, Andreea Manole, Diego-Perez Rodriguez, Romina Durigon, Angela Pyle, Buthaina Albash, Carlo Dionisi-Vici, David Murphy, Diego Martinelli, Enrico Bugiardini, Katrina Allis, Costanza Lamperti, Siegfried Reipert, Lotte Risom, Lucia Laugwitz, Michela Di Nottia, Robert McFarland, Laura Vilarinho, Michael Hanna, Holger Prokisch, Johannes A. Mayr, Enrico Silvio Bertini, Daniele Ghezzi, Elsebet Østergaard, Saskia B. Wortmann, Rosalba Carrozzo, Tobias B. Haack, Robert W. Taylor, Antonella Spinazzola, Karin Nowikovsky, and Henry Houlden. Bi-allelic letm1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. American Journal of Human Genetics, 109:1692-1712, Sep 2022. URL: https://doi.org/10.1016/j.ajhg.2022.07.007, doi:10.1016/j.ajhg.2022.07.007. This article has 21 citations and is from a highest quality peer-reviewed journal.
(kaiyrzhanov2022biallelicletm1variants pages 5-6): Rauan Kaiyrzhanov, Sami E.M. Mohammed, Reza Maroofian, Ralf A. Husain, Alessia Catania, Alessandra Torraco, Ahmad Alahmad, Marina Dutra-Clarke, Sabine Grønborg, Annapurna Sudarsanam, Julie Vogt, Filippo Arrigoni, Julia Baptista, Shahzad Haider, René G. Feichtinger, Paolo Bernardi, Alessandra Zulian, Mirjana Gusic, Stephanie Efthymiou, Renkui Bai, Farah Bibi, Alejandro Horga, Julian A. Martinez-Agosto, Amanda Lam, Andreea Manole, Diego-Perez Rodriguez, Romina Durigon, Angela Pyle, Buthaina Albash, Carlo Dionisi-Vici, David Murphy, Diego Martinelli, Enrico Bugiardini, Katrina Allis, Costanza Lamperti, Siegfried Reipert, Lotte Risom, Lucia Laugwitz, Michela Di Nottia, Robert McFarland, Laura Vilarinho, Michael Hanna, Holger Prokisch, Johannes A. Mayr, Enrico Silvio Bertini, Daniele Ghezzi, Elsebet Østergaard, Saskia B. Wortmann, Rosalba Carrozzo, Tobias B. Haack, Robert W. Taylor, Antonella Spinazzola, Karin Nowikovsky, and Henry Houlden. Bi-allelic letm1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. American Journal of Human Genetics, 109:1692-1712, Sep 2022. URL: https://doi.org/10.1016/j.ajhg.2022.07.007, doi:10.1016/j.ajhg.2022.07.007. This article has 21 citations and is from a highest quality peer-reviewed journal.
(kaiyrzhanov2022biallelicletm1variants pages 8-10): Rauan Kaiyrzhanov, Sami E.M. Mohammed, Reza Maroofian, Ralf A. Husain, Alessia Catania, Alessandra Torraco, Ahmad Alahmad, Marina Dutra-Clarke, Sabine Grønborg, Annapurna Sudarsanam, Julie Vogt, Filippo Arrigoni, Julia Baptista, Shahzad Haider, René G. Feichtinger, Paolo Bernardi, Alessandra Zulian, Mirjana Gusic, Stephanie Efthymiou, Renkui Bai, Farah Bibi, Alejandro Horga, Julian A. Martinez-Agosto, Amanda Lam, Andreea Manole, Diego-Perez Rodriguez, Romina Durigon, Angela Pyle, Buthaina Albash, Carlo Dionisi-Vici, David Murphy, Diego Martinelli, Enrico Bugiardini, Katrina Allis, Costanza Lamperti, Siegfried Reipert, Lotte Risom, Lucia Laugwitz, Michela Di Nottia, Robert McFarland, Laura Vilarinho, Michael Hanna, Holger Prokisch, Johannes A. Mayr, Enrico Silvio Bertini, Daniele Ghezzi, Elsebet Østergaard, Saskia B. Wortmann, Rosalba Carrozzo, Tobias B. Haack, Robert W. Taylor, Antonella Spinazzola, Karin Nowikovsky, and Henry Houlden. Bi-allelic letm1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. American Journal of Human Genetics, 109:1692-1712, Sep 2022. URL: https://doi.org/10.1016/j.ajhg.2022.07.007, doi:10.1016/j.ajhg.2022.07.007. This article has 21 citations and is from a highest quality peer-reviewed journal.
(kaiyrzhanov2022biallelicletm1variants pages 16-17): Rauan Kaiyrzhanov, Sami E.M. Mohammed, Reza Maroofian, Ralf A. Husain, Alessia Catania, Alessandra Torraco, Ahmad Alahmad, Marina Dutra-Clarke, Sabine Grønborg, Annapurna Sudarsanam, Julie Vogt, Filippo Arrigoni, Julia Baptista, Shahzad Haider, René G. Feichtinger, Paolo Bernardi, Alessandra Zulian, Mirjana Gusic, Stephanie Efthymiou, Renkui Bai, Farah Bibi, Alejandro Horga, Julian A. Martinez-Agosto, Amanda Lam, Andreea Manole, Diego-Perez Rodriguez, Romina Durigon, Angela Pyle, Buthaina Albash, Carlo Dionisi-Vici, David Murphy, Diego Martinelli, Enrico Bugiardini, Katrina Allis, Costanza Lamperti, Siegfried Reipert, Lotte Risom, Lucia Laugwitz, Michela Di Nottia, Robert McFarland, Laura Vilarinho, Michael Hanna, Holger Prokisch, Johannes A. Mayr, Enrico Silvio Bertini, Daniele Ghezzi, Elsebet Østergaard, Saskia B. Wortmann, Rosalba Carrozzo, Tobias B. Haack, Robert W. Taylor, Antonella Spinazzola, Karin Nowikovsky, and Henry Houlden. Bi-allelic letm1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. American Journal of Human Genetics, 109:1692-1712, Sep 2022. URL: https://doi.org/10.1016/j.ajhg.2022.07.007, doi:10.1016/j.ajhg.2022.07.007. This article has 21 citations and is from a highest quality peer-reviewed journal.
(kaiyrzhanov2022biallelicletm1variants pages 10-12): Rauan Kaiyrzhanov, Sami E.M. Mohammed, Reza Maroofian, Ralf A. Husain, Alessia Catania, Alessandra Torraco, Ahmad Alahmad, Marina Dutra-Clarke, Sabine Grønborg, Annapurna Sudarsanam, Julie Vogt, Filippo Arrigoni, Julia Baptista, Shahzad Haider, René G. Feichtinger, Paolo Bernardi, Alessandra Zulian, Mirjana Gusic, Stephanie Efthymiou, Renkui Bai, Farah Bibi, Alejandro Horga, Julian A. Martinez-Agosto, Amanda Lam, Andreea Manole, Diego-Perez Rodriguez, Romina Durigon, Angela Pyle, Buthaina Albash, Carlo Dionisi-Vici, David Murphy, Diego Martinelli, Enrico Bugiardini, Katrina Allis, Costanza Lamperti, Siegfried Reipert, Lotte Risom, Lucia Laugwitz, Michela Di Nottia, Robert McFarland, Laura Vilarinho, Michael Hanna, Holger Prokisch, Johannes A. Mayr, Enrico Silvio Bertini, Daniele Ghezzi, Elsebet Østergaard, Saskia B. Wortmann, Rosalba Carrozzo, Tobias B. Haack, Robert W. Taylor, Antonella Spinazzola, Karin Nowikovsky, and Henry Houlden. Bi-allelic letm1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. American Journal of Human Genetics, 109:1692-1712, Sep 2022. URL: https://doi.org/10.1016/j.ajhg.2022.07.007, doi:10.1016/j.ajhg.2022.07.007. This article has 21 citations and is from a highest quality peer-reviewed journal.
(kaiyrzhanov2022biallelicletm1variants pages 17-18): Rauan Kaiyrzhanov, Sami E.M. Mohammed, Reza Maroofian, Ralf A. Husain, Alessia Catania, Alessandra Torraco, Ahmad Alahmad, Marina Dutra-Clarke, Sabine Grønborg, Annapurna Sudarsanam, Julie Vogt, Filippo Arrigoni, Julia Baptista, Shahzad Haider, René G. Feichtinger, Paolo Bernardi, Alessandra Zulian, Mirjana Gusic, Stephanie Efthymiou, Renkui Bai, Farah Bibi, Alejandro Horga, Julian A. Martinez-Agosto, Amanda Lam, Andreea Manole, Diego-Perez Rodriguez, Romina Durigon, Angela Pyle, Buthaina Albash, Carlo Dionisi-Vici, David Murphy, Diego Martinelli, Enrico Bugiardini, Katrina Allis, Costanza Lamperti, Siegfried Reipert, Lotte Risom, Lucia Laugwitz, Michela Di Nottia, Robert McFarland, Laura Vilarinho, Michael Hanna, Holger Prokisch, Johannes A. Mayr, Enrico Silvio Bertini, Daniele Ghezzi, Elsebet Østergaard, Saskia B. Wortmann, Rosalba Carrozzo, Tobias B. Haack, Robert W. Taylor, Antonella Spinazzola, Karin Nowikovsky, and Henry Houlden. Bi-allelic letm1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. American Journal of Human Genetics, 109:1692-1712, Sep 2022. URL: https://doi.org/10.1016/j.ajhg.2022.07.007, doi:10.1016/j.ajhg.2022.07.007. This article has 21 citations and is from a highest quality peer-reviewed journal.
(mcquibban2010adrosophilamutant pages 2-3): Angus G. McQuibban, Nicholas Joza, Aram Megighian, Michele Scorzeto, Damiano Zanini, Siegfried Reipert, Constance Richter, Rudolf J. Schweyen, and Karin Nowikovsky. A drosophila mutant of letm1, a candidate gene for seizures in wolf-hirschhorn syndrome. Human molecular genetics, 19 6:987-1000, Mar 2010. URL: https://doi.org/10.1093/hmg/ddp563, doi:10.1093/hmg/ddp563. This article has 94 citations and is from a domain leading peer-reviewed journal.
(nakamura2020themitochondrialinner pages 1-2): Seiko Nakamura, Aiko Matsui, Shiori Akabane, Yasushi Tamura, Azumi Hatano, Yuriko Miyano, Hiroshi Omote, Mizuho Kajikawa, Katsumi Maenaka, Yoshinori Moriyama, Toshiya Endo, and Toshihiko Oka. The mitochondrial inner membrane protein letm1 modulates cristae organization through its letm domain. Communications Biology, Mar 2020. URL: https://doi.org/10.1038/s42003-020-0832-5, doi:10.1038/s42003-020-0832-5. This article has 63 citations and is from a peer-reviewed journal.
(austin2022tmbim5isthe pages 1-2): Shane Austin, Ronald Mekis, Sami E M Mohammed, Mariafrancesca Scalise, Wen‐An Wang, Michele Galluccio, Christina Pfeiffer, Tamara Borovec, Katja Parapatics, Dijana Vitko, Nora Dinhopl, Nicolas Demaurex, Keiryn L Bennett, Cesare Indiveri, and Karin Nowikovsky. Tmbim5 is the ca2+/h+ antiporter of mammalian mitochondria. EMBO Reports, Nov 2022. URL: https://doi.org/10.15252/embr.202254978, doi:10.15252/embr.202254978. This article has 86 citations and is from a highest quality peer-reviewed journal.
(lin2024anaiinformednmr pages 1-3): Qi Tong Lin, Danielle M. Colussi, Taylor Lake, and Peter Stathopulos. An ai-informed nmr structure reveals a letm1 f-ef-hand for two-way mitochondrial calcium regulation. bioRxiv, Apr 2024. URL: https://doi.org/10.1101/2024.04.23.590744, doi:10.1101/2024.04.23.590744. This article has 0 citations.
(durigon2018letm1couplesmitochondrial pages 1-2): Romina Durigon, Alice L Mitchell, Aleck WE Jones, Andreea Manole, Mara Mennuni, Elizabeth MA Hirst, Henry Houlden, Giuseppe Maragni, Serena Lattante, Paolo Niccolo’ Doronzio, Ilaria Dalla Rosa, Marcella Zollino, Ian J Holt, and Antonella Spinazzola. Letm1 couples mitochondrial dna metabolism and nutrient preference. EMBO Molecular Medicine, Jul 2018. URL: https://doi.org/10.15252/emmm.201708550, doi:10.15252/emmm.201708550. This article has 49 citations and is from a highest quality peer-reviewed journal.
(dao2022thecationexchanger pages 1-2): Pauline Dao, Stefan Hajny, Ronald Mekis, Lukas Orel, Nora Dinhopl, Kristin Tessmar-Raible, and Karin Nowikovsky. The cation exchanger letm1, circadian rhythms, and nad(h) levels interconnect in diurnal zebrafish. Jun 2022. URL: https://doi.org/10.26508/lsa.202101194, doi:10.26508/lsa.202101194. This article has 9 citations and is from a peer-reviewed journal.
(dao2022thecationexchanger pages 2-4): Pauline Dao, Stefan Hajny, Ronald Mekis, Lukas Orel, Nora Dinhopl, Kristin Tessmar-Raible, and Karin Nowikovsky. The cation exchanger letm1, circadian rhythms, and nad(h) levels interconnect in diurnal zebrafish. Jun 2022. URL: https://doi.org/10.26508/lsa.202101194, doi:10.26508/lsa.202101194. This article has 9 citations and is from a peer-reviewed journal.
(huang2017pink1mediatedphosphorylationof pages 1-2): En Huang, Dianbo Qu, Tianwen Huang, Nicoletta Rizzi, Wassamon Boonying, Dorothy Krolak, Paolo Ciana, John Woulfe, Christine Klein, Ruth S. Slack, Daniel Figeys, and David S. Park. Pink1-mediated phosphorylation of letm1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress. Nature Communications, Nov 2017. URL: https://doi.org/10.1038/s41467-017-01435-1, doi:10.1038/s41467-017-01435-1. This article has 128 citations and is from a highest quality peer-reviewed journal.
(mcquibban2010adrosophilamutant pages 1-2): Angus G. McQuibban, Nicholas Joza, Aram Megighian, Michele Scorzeto, Damiano Zanini, Siegfried Reipert, Constance Richter, Rudolf J. Schweyen, and Karin Nowikovsky. A drosophila mutant of letm1, a candidate gene for seizures in wolf-hirschhorn syndrome. Human molecular genetics, 19 6:987-1000, Mar 2010. URL: https://doi.org/10.1093/hmg/ddp563, doi:10.1093/hmg/ddp563. This article has 94 citations and is from a domain leading peer-reviewed journal.

Artifacts

Edison artifact artifact-00

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	8
Resolved	8
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	8
On topic	3
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	49
Resolved	48
Unresolved (possible confabulation)	1
Obsolete	0
Unverifiable	0
Terms whose name was checked	4
Terms named correctly	1
Terms named as a different term	2
Terms whose name is worth a second look	1

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

HP:0100022 (1 mention) - the report calls it "Hyperkinetic movements — approximately 33%: HPO: Hyperkinetic movements"; HP calls it Abnormality of movement
HP:0000518 (1 mention) - the report calls it "Bilateral cataracts — approximately 42–45%: HPO: Cataract"; HP calls it Cataract

Unresolved terms

These identifiers do not exist in an ontology that resolved other terms from the same prefix, so they were most likely invented:

HP:0001244 (1 mention) - HP does not contain this term

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

HP:0000819 (1 mention) - the report calls it "Diabetes mellitus — 27%: HPO: Diabetes mellitus"; HP calls it Diabetes mellitus

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Biochemical Markers

Progression

Prevalence

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

LETM1-Related Childhood-Onset Neurodegeneration: Disease Characteristics Report

Executive summary

1. Disease information

Definition and scope

Identifiers and synonyms

2. Etiology, risk, and protective factors

Causal factor

Risk factors

Protective factors and gene–environment interaction

3. Phenotypes

Core neurological and developmental phenotypes

Neurosensory, muscular, and imaging phenotypes

Multisystem phenotypes

Laboratory abnormalities

4. Genetic and molecular information

Gene and protein

Variant interpretation

Modifiers, epigenetics, and chromosomal abnormalities

5. Environmental information

6. Mechanism and pathophysiology

Ordered causal chain

Current mechanistic interpretation and controversy

Cellular processes, pathways, and ontology suggestions

Molecular profiling and advanced technologies

7. Anatomical structures affected

Organ and system level

Subcellular level

8. Temporal development

9. Inheritance and population

10. Diagnostics

When to suspect

Recommended evaluation

Differential diagnosis

11. Outcome and prognosis

12. Treatment and current applications

Current clinical management

Experimental approaches

13. Prevention

14. Other species and natural disease

15. Model organisms and experimental systems

Mouse

Drosophila

Zebrafish

Yeast and other lower eukaryotes

Patient cells and reconstituted systems

Recent developments and expert assessment

Evidence limitations

Artifacts

Reference Validation

Term Validation

Terms the report names something else

Unresolved terms

Terms whose name is worth a second look